| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FLI1 NCOA3 POU6F2 SALL3 ZNF628 NRL EBF3 RBL2 MAZ POU3F3 RFX6 RREB1 KLF4 CREBBP MEF2A MYEF2 EBF2 BPTF OTP USF3 OTX2 ZFHX4 ASCL1 NFIC GLI1 PITX1 SMARCA4 NCOA1 ZFHX3 KLF17 PAX3 EN1 EP300 TP73 PRRX2 TBX2 NOBOX | 2.62e-11 | 1459 | 149 | 37 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 6.99e-11 | 11 | 149 | 6 | GO:0004523 | |
| GeneOntologyMolecularFunction | chromatin binding | FLI1 NCOA3 EP400 NRL RBL2 MAZ TSPY4 TSPY9 ARID1A KLF4 CREBBP MEF2A NCOA5 EBF2 ARID1B TNRC18 ZC3H4 ASCL1 GLI1 SMARCA2 SMARCA4 NCOA1 PAX3 NONO EP300 | 2.31e-10 | 739 | 149 | 25 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FLI1 NCOA3 POU6F2 SALL3 ZNF628 NRL EBF3 MAZ ADNP2 POU3F3 RFX6 RREB1 KLF4 MEF2A MYEF2 EBF2 OTP KMT2D USF3 OTX2 ZFHX4 ASCL1 NFIC GLI1 PITX1 ZFHX3 KLF17 PAX3 EN1 NOTCH4 TP73 PRRX2 TBX2 NOBOX | 7.91e-10 | 1412 | 149 | 34 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FLI1 POU6F2 SALL3 ZNF628 NRL EBF3 MAZ POU3F3 RFX6 RREB1 KLF4 MEF2A MYEF2 EBF2 BPTF OTX2 ZFHX4 ASCL1 NFIC GLI1 PITX1 SMARCA4 ZFHX3 KLF17 PAX3 EN1 EP300 NOTCH4 TP73 PRRX2 TBX2 NOBOX | 9.31e-10 | 1271 | 149 | 32 | GO:0000987 |
| GeneOntologyMolecularFunction | transcription coactivator activity | ZXDC BCL9L NCOA3 MED30 DTX1 BCL9 ARID1A CREBBP ARID1B KMT2D SS18L1 MED12L SMARCA2 SMARCA4 NCOA1 EP300 | 1.06e-09 | 303 | 149 | 16 | GO:0003713 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FLI1 POU6F2 SALL3 ZNF628 NRL EBF3 MAZ POU3F3 RFX6 RREB1 KLF4 MEF2A MYEF2 EBF2 BPTF OTX2 ZFHX4 ASCL1 NFIC GLI1 PITX1 SMARCA4 ZFHX3 KLF17 PAX3 EN1 EP300 TP73 PRRX2 TBX2 NOBOX | 2.30e-09 | 1244 | 149 | 31 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FLI1 NCOA3 ZNF628 NRL EBF3 RFX6 RREB1 KLF4 MEF2A EBF2 KMT2D USF3 OTX2 NFIC GLI1 PITX1 NOTCH4 TP73 PRRX2 NOBOX | 7.06e-09 | 560 | 149 | 20 | GO:0001228 |
| GeneOntologyMolecularFunction | transcription coregulator activity | ZXDC BCL9L NCOA3 TOB2 MED30 SUPT20H DTX1 BCL9 ARID1A CREBBP NCOA5 ARID1B KMT2D SS18L1 MED12L SMARCA2 SMARCA4 NCOA1 EP300 PARP15 | 7.49e-09 | 562 | 149 | 20 | GO:0003712 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FLI1 NCOA3 ZNF628 NRL EBF3 RFX6 RREB1 KLF4 MEF2A EBF2 KMT2D USF3 OTX2 NFIC GLI1 PITX1 NOTCH4 TP73 PRRX2 NOBOX | 8.44e-09 | 566 | 149 | 20 | GO:0001216 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.10e-08 | 14 | 149 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.00e-07 | 37 | 149 | 6 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.00e-07 | 37 | 149 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.54e-07 | 38 | 149 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.00e-07 | 21 | 149 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ZXDC BCL9L NCOA3 TOB2 MED30 SUPT20H DTX1 BCL9 ARID1A KLF4 CREBBP SH2B1 STRIP1 NCOA5 ARID1B KMT2D SS18L1 TNRC6A MED12L SMARCA2 SMARCA4 NCOA1 RBM47 EP300 WNK3 PARP15 | 4.40e-07 | 1160 | 149 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA3 TOB2 MED30 PCLO MDFI ARID1A KLF4 CREBBP MEF2A BPTF ASCL1 PITX1 MED25 MED12L SMARCA4 NCOA1 PAX3 EP300 TP73 TBX2 | 8.53e-07 | 753 | 149 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.14e-06 | 46 | 149 | 6 | GO:0016893 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ZXDC BCL9L NCOA3 TOB2 MED30 SUPT20H SASH1 DTX1 BCL9 ARID1A KLF4 CREBBP SH2B1 STRIP1 NCOA5 ARID1B KMT2D SS18L1 TNRC6A MED12L SMARCA2 SMARCA4 NCOA1 RBM47 EP300 WNK3 PARP15 | 2.51e-06 | 1356 | 149 | 27 | GO:0060090 |
| GeneOntologyMolecularFunction | methyl-CpG binding | 3.14e-06 | 31 | 149 | 5 | GO:0008327 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA3 TOB2 MED30 MDFI ARID1A KLF4 CREBBP MEF2A ASCL1 PITX1 MED25 SMARCA4 NCOA1 EP300 TP73 TBX2 | 7.53e-06 | 582 | 149 | 16 | GO:0140297 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.90e-06 | 38 | 149 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.04e-05 | 140 | 149 | 8 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA3 TOB2 MED30 ARID1A KLF4 CREBBP MEF2A PITX1 MED25 SMARCA4 NCOA1 EP300 TP73 | 1.53e-05 | 417 | 149 | 13 | GO:0061629 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.32e-05 | 46 | 149 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 2.77e-05 | 79 | 149 | 6 | GO:0004521 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 EP400 ERVK-7 ERVK-10 ARID1A BPTF ERVK-8 SMARCA2 SMARCA4 ERVK-11 | 2.81e-05 | 262 | 149 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.85e-05 | 51 | 149 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.53e-05 | 2 | 149 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.53e-05 | 2 | 149 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 5.57e-05 | 55 | 149 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.24e-05 | 187 | 149 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 8.49e-05 | 60 | 149 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.30e-04 | 104 | 149 | 6 | GO:0016407 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.47e-04 | 152 | 149 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.62e-04 | 37 | 149 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.65e-04 | 3 | 149 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.83e-04 | 120 | 149 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.95e-04 | 78 | 149 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | structural molecule activity | AMBN ERVK-6 COL4A5 COL12A1 COL15A1 COL17A1 COMP PCLO COL5A3 ERVK-7 ERVK-10 TLN1 ERVK-8 ERVK-18 ERVK-25 TUBAL3 OTOG | 3.60e-04 | 891 | 149 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.93e-04 | 83 | 149 | 5 | GO:1990841 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.91e-04 | 21 | 149 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.34e-04 | 188 | 149 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 5.53e-04 | 136 | 149 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 5.53e-04 | 136 | 149 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 6.46e-04 | 23 | 149 | 3 | GO:0071837 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.01e-03 | 102 | 149 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.89e-03 | 33 | 149 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.63e-03 | 37 | 149 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | p53 binding | 2.64e-03 | 77 | 149 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.65e-03 | 127 | 149 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 4.75e-03 | 14 | 149 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 5.45e-03 | 15 | 149 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | protein antigen binding | 6.20e-03 | 16 | 149 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.53e-03 | 51 | 149 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ADAMTS3 DTX1 CUL9 ERVK-7 ERVK-10 KLF4 CREBBP RBM20 ZFHX4 ERVK-8 ZFHX3 ERVK-11 EP300 | 6.90e-03 | 891 | 149 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 6.99e-03 | 17 | 149 | 2 | GO:0070742 | |
| GeneOntologyMolecularFunction | histone modifying activity | 7.52e-03 | 229 | 149 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 7.65e-03 | 54 | 149 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 7.82e-03 | 18 | 149 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | nuclease activity | 7.83e-03 | 231 | 149 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 9.00e-03 | 238 | 149 | 6 | GO:0016747 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 EP400 ERVK-7 ERVK-10 ARID1A BPTF NYNRIN ERVK-8 SMARCA2 SMARCA4 ERVK-11 | 9.12e-03 | 645 | 149 | 11 | GO:0140640 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FLI1 BCL9L NCOA3 MED30 SUPT20H NRL EBF3 MAZ POU3F3 RFX6 RREB1 BCL9 KLF4 CREBBP MEF2A EBF2 BPTF KMT2D USF3 OTX2 ASCL1 NFIC GLI1 SS18L1 PITX1 MED25 MED12L SMARCA2 SMARCA4 NCOA1 ZFHX3 PAX3 EN1 EP300 NOTCH4 TP73 PRRX2 TBX2 NOBOX | 8.05e-14 | 1390 | 148 | 39 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MBD3L5 MBD3L2 MAZ POU3F3 MBD3L3 MBD3L4 MDFI RREB1 ARID1A KLF4 CREBBP MEF2A MYEF2 MBD3L2B NCOA5 BPTF OTP ASCL1 NFIC MED25 SMARCA2 SMARCA4 ZFHX3 KLF17 PAX3 EN1 SAP130 EP300 NOTCH4 TBX2 PARP15 | 1.43e-11 | 1053 | 148 | 31 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | MBD3L5 TOB2 MBD3L2 MAZ POU3F3 MBD3L3 MBD3L4 MDFI RREB1 ARID1A KLF4 CREBBP MEF2A MYEF2 MBD3L2B NCOA5 BPTF OTP ZC3H4 ASCL1 NFIC PITX1 MED25 SMARCA2 SMARCA4 ZFHX3 KLF17 PAX3 EN1 NONO SAP130 EP300 NOTCH4 TBX2 PARP15 | 5.08e-11 | 1399 | 148 | 35 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MBD3L5 TOB2 MBD3L2 MAZ POU3F3 MBD3L3 MBD3L4 MDFI RREB1 ARID1A KLF4 CREBBP MEF2A MYEF2 MBD3L2B NCOA5 BPTF OTP ZC3H4 ASCL1 NFIC PITX1 MED25 SMARCA2 SMARCA4 ZFHX3 KLF17 PAX3 EN1 NONO SAP130 EP300 NOTCH4 TBX2 PARP15 | 6.68e-11 | 1413 | 148 | 35 | GO:1902679 |
| GeneOntologyBiologicalProcess | DNA integration | 2.03e-10 | 13 | 148 | 6 | GO:0015074 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | NCOA3 COL12A1 SUPT20H SOBP MDFI ARID1A KLF4 CREBBP PTK7 OTX2 GLI1 BRPF1 PITX1 SMARCA4 CHRD NCOA1 COBL PAX3 EN1 PRRX2 TBX2 | 4.11e-08 | 713 | 148 | 21 | GO:0048598 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MBD3L5 NCOA3 MED30 EP400 MBD3L2 RBL2 TSPY4 TSPY9 MBD3L3 MBD3L4 ARID1A CREBBP MBD3L2B BPTF ARID1B KMT2D BRPF1 SS18L1 NFRKB MED25 SMARCA2 SMARCA4 NCOA1 SPOCD1 EP300 | 4.53e-08 | 999 | 148 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | cell fate determination | 6.55e-08 | 50 | 148 | 7 | GO:0001709 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MBD3L5 NCOA3 EP400 MBD3L2 TSPY4 TSPY9 MBD3L3 MBD3L4 ARID1A CREBBP MBD3L2B BPTF ARID1B KMT2D BRPF1 NFRKB SMARCA2 SMARCA4 NCOA1 SPOCD1 EP300 | 7.89e-08 | 741 | 148 | 21 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | MBD3L5 NCOA3 EP400 MBD3L2 RBL2 TSPY4 TSPY9 MBD3L3 MBD3L4 ARID1A CREBBP MBD3L2B BPTF ARID1B KMT2D BRPF1 SS18L1 NFRKB SMARCA2 SMARCA4 NCOA1 SPOCD1 EP300 | 1.07e-07 | 896 | 148 | 23 | GO:0006325 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 6.10e-07 | 136 | 148 | 9 | GO:0045445 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 6.95e-07 | 44 | 148 | 6 | GO:0006346 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 SUPT20H EP400 WDR33 ERVK-7 ERVK-10 ARID1A CREBBP ARID1B CSNK2A1 NYNRIN NFRKB ERVK-8 SMARCA2 SMARCA4 ERVK-11 NONO TP73 | 9.66e-07 | 648 | 148 | 18 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.18e-06 | 48 | 148 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 2.68e-06 | 55 | 148 | 6 | GO:0140718 | |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 COL12A1 SUPT20H ADAMTS3 SOBP MDFI ARID1A KLF4 CREBBP PTK7 BPTF KMT2D OTX2 GLI1 BRPF1 PITX1 NFRKB SMARCA4 CHRD NCOA1 COBL RBM46 PAX3 EN1 EP300 PRRX2 TBX2 | 3.56e-06 | 1437 | 148 | 27 | GO:0009790 |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA3 ADAMTS3 MDFI ARID1A KLF4 PTK7 BPTF KMT2D OTX2 BRPF1 SMARCA4 CHRD NCOA1 COBL RBM46 PAX3 EN1 EP300 PRRX2 TBX2 | 7.73e-06 | 906 | 148 | 20 | GO:0043009 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | BCL9L NCOA3 MED30 BCL9 ARID1A KLF4 CREBBP SMARCA2 SMARCA4 SAP130 | 8.46e-06 | 237 | 148 | 10 | GO:0019827 |
| GeneOntologyBiologicalProcess | DNA metabolic process | ERVK-6 SUPT20H EP400 WDR33 ERVK-7 ERVK-10 ARID1A KLF4 CREBBP SH2B1 ARID1B NFIC GLI1 CSNK2A1 NYNRIN NFRKB ERVK-8 SMARCA2 SMARCA4 ERVK-11 NONO TP73 | 9.42e-06 | 1081 | 148 | 22 | GO:0006259 |
| GeneOntologyBiologicalProcess | maintenance of cell number | BCL9L NCOA3 MED30 BCL9 ARID1A KLF4 CREBBP SMARCA2 SMARCA4 SAP130 | 1.02e-05 | 242 | 148 | 10 | GO:0098727 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA3 ADAMTS3 MDFI ARID1A KLF4 PTK7 BPTF KMT2D OTX2 BRPF1 SMARCA4 CHRD NCOA1 COBL RBM46 PAX3 EN1 EP300 PRRX2 TBX2 | 1.11e-05 | 929 | 148 | 20 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryonic organ development | NCOA3 SOBP MDFI ARID1A PTK7 BPTF OTX2 GLI1 SMARCA4 CHRD NCOA1 COBL EN1 PRRX2 TBX2 | 1.29e-05 | 561 | 148 | 15 | GO:0048568 |
| GeneOntologyBiologicalProcess | heterochromatin formation | 2.36e-05 | 163 | 148 | 8 | GO:0031507 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | MBD3L5 MBD3L2 MBD3L3 MBD3L4 ARID1A MBD3L2B ARID1B KMT2D SMARCA4 SPOCD1 EP300 | 2.71e-05 | 330 | 148 | 11 | GO:0040029 |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 3.20e-05 | 51 | 148 | 5 | GO:1902459 | |
| GeneOntologyBiologicalProcess | cell fate commitment | KLF4 EBF2 OTX2 ASCL1 PITX1 SMARCA4 CHRD PAX3 EP300 NOTCH4 TBX2 | 3.38e-05 | 338 | 148 | 11 | GO:0045165 |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 4.24e-05 | 54 | 148 | 5 | GO:0045663 | |
| GeneOntologyBiologicalProcess | artery development | 4.97e-05 | 133 | 148 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | SUPT20H EP400 ARID1A CREBBP ARID1B CSNK2A1 NFRKB SMARCA2 SMARCA4 | 4.99e-05 | 234 | 148 | 9 | GO:0006282 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 5.26e-05 | 29 | 148 | 4 | GO:2000819 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.29e-05 | 92 | 148 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 SUPT20H EP400 WDR33 ERVK-7 ERVK-10 ARID1A CREBBP ARID1B CSNK2A1 NYNRIN NFRKB ERVK-8 SMARCA2 SMARCA4 ERVK-11 NONO EP300 TP73 | 5.82e-05 | 959 | 148 | 19 | GO:0006974 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 6.34e-05 | 95 | 148 | 6 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 7.33e-05 | 246 | 148 | 9 | GO:1902806 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | TCF19 RBL2 ARID1A KLF4 CREBBP ARID1B GLI1 SMARCA2 SMARCA4 TBX2 | 7.48e-05 | 306 | 148 | 10 | GO:0044843 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 7.87e-05 | 143 | 148 | 7 | GO:0045739 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 8.97e-05 | 146 | 148 | 7 | GO:2000779 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 1.11e-04 | 203 | 148 | 8 | GO:0045814 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 1.23e-04 | 107 | 148 | 6 | GO:0009953 | |
| GeneOntologyBiologicalProcess | regionalization | TMEM67 MDFI BPTF OTX2 ASCL1 GLI1 CHRD COBL PAX3 EN1 EP300 TBX2 | 1.77e-04 | 478 | 148 | 12 | GO:0003002 |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 1.82e-04 | 218 | 148 | 8 | GO:0071897 | |
| GeneOntologyBiologicalProcess | forebrain development | SALL3 POU3F3 ARID1A OTP OTX2 ASCL1 GLI1 PITX1 SMARCA4 CHRD NCOA1 TP73 | 2.18e-04 | 489 | 148 | 12 | GO:0030900 |
| GeneOntologyBiologicalProcess | limb development | 2.19e-04 | 224 | 148 | 8 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 2.19e-04 | 224 | 148 | 8 | GO:0048736 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 2.30e-04 | 42 | 148 | 4 | GO:0070316 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 2.46e-04 | 78 | 148 | 5 | GO:2000036 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 2.69e-04 | 231 | 148 | 8 | GO:0006352 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 2.76e-04 | 44 | 148 | 4 | GO:0045023 | |
| GeneOntologyBiologicalProcess | aorta development | 2.77e-04 | 80 | 148 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 3.04e-04 | 4 | 148 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | head development | TMEM67 SALL3 POU3F3 ARID1A CREBBP BPTF OTP OTX2 ASCL1 GLI1 PITX1 SMARCA4 CHRD NCOA1 EN1 EP300 TP73 | 3.27e-04 | 919 | 148 | 17 | GO:0060322 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.29e-04 | 83 | 148 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 EP400 ERVK-7 ERVK-10 CREBBP CSNK2A1 NFRKB ERVK-8 ERVK-11 NONO | 3.33e-04 | 368 | 148 | 10 | GO:0006310 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | TMEM67 SUPT20H EP400 ARID1A KLF4 CREBBP ARID1B CSNK2A1 NFRKB SMARCA2 SMARCA4 EP300 TP73 | 3.84e-04 | 598 | 148 | 13 | GO:0080135 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.85e-04 | 185 | 148 | 7 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.85e-04 | 185 | 148 | 7 | GO:0035108 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 3.97e-04 | 186 | 148 | 7 | GO:0006367 | |
| GeneOntologyBiologicalProcess | pattern specification process | TMEM67 MDFI BPTF OTX2 ASCL1 GLI1 CHRD COBL PAX3 EN1 EP300 TBX2 | 4.22e-04 | 526 | 148 | 12 | GO:0007389 |
| GeneOntologyBiologicalProcess | tube development | TMEM67 NCOA3 COL15A1 COMP SASH1 POU3F3 ARID1A KLF4 PTK7 ASCL1 GLI1 BRPF1 SMARCA4 CHRD COBL PAX3 EN1 EP300 NOTCH4 TP73 PRRX2 TBX2 | 4.28e-04 | 1402 | 148 | 22 | GO:0035295 |
| GeneOntologyBiologicalProcess | DNA replication | 4.31e-04 | 312 | 148 | 9 | GO:0006260 | |
| GeneOntologyBiologicalProcess | diencephalon development | 4.79e-04 | 90 | 148 | 5 | GO:0021536 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 5.29e-04 | 92 | 148 | 5 | GO:0045661 | |
| GeneOntologyBiologicalProcess | response to growth factor | BCL9L COMP ADAMTS3 BCL9 KLF4 CREBBP BPTF OTX2 ASCL1 CHRD CSTF2 ZFHX3 SAP130 SLC39A5 EP300 TBX2 | 6.17e-04 | 883 | 148 | 16 | GO:0070848 |
| GeneOntologyBiologicalProcess | circulatory system development | TMEM67 COL15A1 COMP SASH1 ARID1A KLF4 MEF2A RBM20 PTK7 ASCL1 GLI1 BRPF1 SMARCA2 SMARCA4 CHRD PAX3 EP300 GAA NOTCH4 TP73 PRRX2 TBX2 | 6.25e-04 | 1442 | 148 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | neural tube development | 6.50e-04 | 202 | 148 | 7 | GO:0021915 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | TMEM67 EP400 RBL2 CUL9 TSC22D2 ARID1A KLF4 CREBBP SH2B1 ARID1B ASCL1 GLI1 CSNK2A1 NFRKB SMARCA2 SMARCA4 RBM46 CSNK2A3 TP73 TBX2 | 6.65e-04 | 1256 | 148 | 20 | GO:0051726 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 6.88e-04 | 333 | 148 | 9 | GO:0051054 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 7.04e-04 | 148 | 148 | 6 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 7.04e-04 | 148 | 148 | 6 | GO:0035113 | |
| GeneOntologyBiologicalProcess | gland development | NCOA3 RREB1 OTP ASCL1 GLI1 PITX1 SMARCA4 NCOA1 COBL PAX3 NOTCH4 TBX2 | 7.10e-04 | 558 | 148 | 12 | GO:0048732 |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 7.40e-04 | 99 | 148 | 5 | GO:0051145 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 7.53e-04 | 6 | 148 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | AMBN FLI1 TMEM67 NCOA3 COMP NRL SOBP MDFI ARID1A RBM20 PTK7 OTX2 NFIC GLI1 SMARCA4 PAX3 EP300 GAA PRRX2 TBX2 | 7.55e-04 | 1269 | 148 | 20 | GO:0009887 |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 7.74e-04 | 271 | 148 | 8 | GO:0000082 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | SUPT20H EP400 ARID1A KLF4 CREBBP SH2B1 ARID1B GLI1 CSNK2A1 NFRKB SMARCA2 SMARCA4 | 7.79e-04 | 564 | 148 | 12 | GO:0051052 |
| GeneOntologyBiologicalProcess | epithelium development | TMEM67 NCOA3 POU3F3 RFX6 RREB1 ARID1A KLF4 PTK7 OTP OTX2 ASCL1 GLI1 BRPF1 SMARCA4 CHRD COBL PAX3 EN1 EP300 NOTCH4 TP73 TBX2 | 7.99e-04 | 1469 | 148 | 22 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 8.88e-04 | 213 | 148 | 7 | GO:2000045 | |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 9.65e-04 | 105 | 148 | 5 | GO:0008589 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 9.97e-04 | 351 | 148 | 9 | GO:0048562 | |
| GeneOntologyBiologicalProcess | heart development | TMEM67 ARID1A MEF2A RBM20 PTK7 ASCL1 GLI1 SMARCA4 CHRD PAX3 EP300 GAA TP73 TBX2 | 1.12e-03 | 757 | 148 | 14 | GO:0007507 |
| GeneOntologyBiologicalProcess | mammary gland development | 1.13e-03 | 162 | 148 | 6 | GO:0030879 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | TMEM67 NCOA3 COL15A1 COMP SASH1 ARID1A KLF4 PTK7 GLI1 BRPF1 SMARCA4 CHRD COBL PAX3 NOTCH4 TP73 PRRX2 TBX2 | 1.19e-03 | 1125 | 148 | 18 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | RBL2 CUL9 ARID1A KLF4 CREBBP SH2B1 ARID1B ASCL1 SMARCA2 SMARCA4 RBM46 TP73 | 1.22e-03 | 594 | 148 | 12 | GO:0007346 |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.23e-03 | 65 | 148 | 4 | GO:0045815 | |
| GeneOntologyBiologicalProcess | muscle structure development | BCL9L COMP BCL9 ARID1A MEF2A ARID1B PITX1 SMARCA2 SMARCA4 ZFHX3 PAX3 FER1L5 EP300 NOTCH4 TBX2 | 1.31e-03 | 858 | 148 | 15 | GO:0061061 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 1.45e-03 | 68 | 148 | 4 | GO:0141137 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 1.49e-03 | 372 | 148 | 9 | GO:0060485 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | COMP BCL9 ARID1A MEF2A SMARCA2 SMARCA4 PAX3 FER1L5 EP300 NOTCH4 TBX2 | 1.59e-03 | 531 | 148 | 11 | GO:0042692 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | AMBN COL4A5 COL12A1 COL15A1 COL17A1 COMP ADAMTS3 COL5A3 SMARCA4 | 1.63e-03 | 377 | 148 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | AMBN COL4A5 COL12A1 COL15A1 COL17A1 COMP ADAMTS3 COL5A3 SMARCA4 | 1.66e-03 | 378 | 148 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | AMBN COL4A5 COL12A1 COL15A1 COL17A1 COMP ADAMTS3 COL5A3 SMARCA4 | 1.69e-03 | 379 | 148 | 9 | GO:0045229 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | TMEM67 NCOA3 RREB1 ARID1A KLF4 PTK7 BRPF1 SMARCA4 COBL PAX3 NOTCH4 TBX2 | 1.72e-03 | 619 | 148 | 12 | GO:0002009 |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 1.72e-03 | 176 | 148 | 6 | GO:0007224 | |
| GeneOntologyBiologicalProcess | mammary gland formation | 1.78e-03 | 9 | 148 | 2 | GO:0060592 | |
| GeneOntologyBiologicalProcess | gonadal mesoderm development | 1.78e-03 | 9 | 148 | 2 | GO:0007506 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.82e-03 | 178 | 148 | 6 | GO:0006261 | |
| GeneOntologyCellularComponent | chromatin | FLI1 NCOA3 POU6F2 SUPT20H EP400 NRL EBF3 RBL2 TSPY4 ADNP2 POU3F3 TSPY9 RFX6 ARID1A KLF4 CREBBP MEF2A EBF2 BPTF OTP ARID1B OTX2 ZFHX4 ASCL1 NFIC CSNK2A1 BRPF1 SS18L1 PITX1 NFRKB SMARCA2 SMARCA4 NCOA1 ZFHX3 KLF17 PAX3 EN1 SAP130 EP300 TP73 PRRX2 TBX2 NOBOX | 5.20e-16 | 1480 | 148 | 43 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L NCOA3 MED30 RBL2 BCL9 POLR1G KLF4 CREBBP MEF2A OTX2 ASCL1 PITX1 MED25 NCOA1 ZFHX3 PAX3 NONO EP300 TBX2 NOBOX | 8.36e-09 | 596 | 148 | 20 | GO:0005667 |
| GeneOntologyCellularComponent | nBAF complex | 6.82e-08 | 16 | 148 | 5 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 4.09e-07 | 96 | 148 | 8 | GO:0070603 | |
| GeneOntologyCellularComponent | bBAF complex | 4.90e-07 | 10 | 148 | 4 | GO:0140092 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L NCOA3 MED30 EP400 WDR33 U2AF2 BCL9 ARID1A POLR1G CREBBP BPTF ARID1B KMT2D ASCL1 CSNK2A1 SS18L1 NFRKB MED25 MED12L SMARCA2 SMARCA4 CSTF2 NCOA1 RBM47 NONO SAP130 CSTF2T | 1.24e-06 | 1377 | 148 | 27 | GO:0140513 |
| GeneOntologyCellularComponent | npBAF complex | 2.29e-06 | 14 | 148 | 4 | GO:0071564 | |
| GeneOntologyCellularComponent | ATPase complex | 3.86e-06 | 129 | 148 | 8 | GO:1904949 | |
| GeneOntologyCellularComponent | fibrillar center | 1.57e-05 | 156 | 148 | 8 | GO:0001650 | |
| GeneOntologyCellularComponent | collagen trimer | 3.82e-05 | 88 | 148 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 5.73e-05 | 30 | 148 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | brahma complex | 1.20e-04 | 14 | 148 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.42e-04 | 272 | 148 | 9 | GO:0090575 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 2.96e-04 | 4 | 148 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 5.50e-04 | 94 | 148 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 8.02e-04 | 26 | 148 | 3 | GO:0005847 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 8.71e-04 | 104 | 148 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.08e-03 | 109 | 148 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.35e-03 | 31 | 148 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.36e-03 | 8 | 148 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | nuclear body | FLI1 EP400 DTX1 U2AF2 PATL1 RREB1 CREBBP OTP CSNK2A1 SS18L1 CSTF2 ZFHX3 SCAF11 NONO SAP130 | 1.90e-03 | 903 | 148 | 15 | GO:0016604 |
| GeneOntologyCellularComponent | mediator complex | 2.27e-03 | 37 | 148 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.69e-03 | 13 | 148 | 2 | GO:1990907 | |
| HumanPheno | Abnormality of mouth size | TMEM67 GALNS ADAMTS3 RREB1 ARID1A CREBBP SH2B1 BPTF ARID1B OTX2 BRPF1 MED12L SMARCA2 SMARCA4 PACS2 PAX3 NONO EP300 | 1.58e-06 | 425 | 62 | 18 | HP:0011337 |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.72e-06 | 3 | 62 | 3 | HP:0005895 | |
| HumanPheno | Thick eyebrow | EBF3 U2AF2 ARID1A CREBBP BPTF ARID1B SMARCA2 SMARCA4 PAX3 EP300 | 1.32e-05 | 154 | 62 | 10 | HP:0000574 |
| HumanPheno | Prominent fingertip pads | 1.63e-05 | 46 | 62 | 6 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 2.09e-05 | 48 | 62 | 6 | HP:0011298 | |
| HumanPheno | Reduced circulating growth hormone concentration | 2.46e-05 | 15 | 62 | 4 | HP:0034323 | |
| HumanPheno | Prominent interphalangeal joints | 3.35e-05 | 6 | 62 | 3 | HP:0006237 | |
| HumanPheno | Narrow nasal bridge | 3.74e-05 | 53 | 62 | 6 | HP:0000446 | |
| HumanPheno | Short philtrum | ADAMTS3 RREB1 ARID1A CREBBP BPTF ARID1B BRPF1 MED25 MED12L SMARCA2 SMARCA4 NONO | 4.06e-05 | 253 | 62 | 12 | HP:0000322 |
| HumanPheno | Prominent eyelashes | 4.21e-05 | 17 | 62 | 4 | HP:0011231 | |
| HumanPheno | Delayed ability to walk | COL12A1 GALNS EBF3 RBL2 CREBBP ARID1B CSNK2A1 BRPF1 SMARCA2 PACS2 COASY NONO EP300 | 5.49e-05 | 304 | 62 | 13 | HP:0031936 |
| HumanPheno | Hypertelorism | FLI1 TMEM67 ADAMTS3 EBF3 RBL2 RREB1 CREBBP SH2B1 BPTF ARID1B KMT2D CSNK2A1 BRPF1 PITX1 MED25 MED12L SMARCA2 PACS2 PAX3 NONO EP300 WNK3 TBX2 | 5.60e-05 | 830 | 62 | 23 | HP:0000316 |
| HumanPheno | Deviated nasal septum | 5.81e-05 | 7 | 62 | 3 | HP:0004411 | |
| HumanPheno | Low anterior hairline | 5.98e-05 | 147 | 62 | 9 | HP:0000294 | |
| HumanPheno | Abnormal eyebrow morphology | FLI1 TMEM67 ADAMTS3 EBF3 RBL2 U2AF2 ARID1A CREBBP BPTF ARID1B KMT2D OTX2 CSNK2A1 MED25 MED12L SMARCA2 SMARCA4 PACS2 PAX3 EP300 | 8.13e-05 | 674 | 62 | 20 | HP:0000534 |
| HumanPheno | Abnormal finger phalanx morphology | FLI1 TMEM67 COL12A1 COMP ADAMTS3 RREB1 ARID1A CREBBP SH2B1 BPTF ARID1B KMT2D GLI1 PITX1 MED25 SMARCA2 SMARCA4 PAX3 NONO EP300 TBX2 | 9.33e-05 | 738 | 62 | 21 | HP:0005918 |
| HumanPheno | High, narrow palate | 9.50e-05 | 156 | 62 | 9 | HP:0002705 | |
| HumanPheno | Narrow mouth | ADAMTS3 RREB1 CREBBP SH2B1 BPTF OTX2 BRPF1 MED12L PAX3 NONO EP300 | 9.66e-05 | 234 | 62 | 11 | HP:0000160 |
| HumanPheno | Narrow palate | COL12A1 PCLO CREBBP KMT2D MED25 MED12L SMARCA2 NONO EP300 TBX2 | 1.36e-04 | 202 | 62 | 10 | HP:0000189 |
| HumanPheno | Pilomatrixoma | 1.37e-04 | 9 | 62 | 3 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 1.37e-04 | 9 | 62 | 3 | HP:0002341 | |
| HumanPheno | Sandal gap | 1.43e-04 | 96 | 62 | 7 | HP:0001852 | |
| HumanPheno | Plantar crease between first and second toes | 1.46e-04 | 2 | 62 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.46e-04 | 2 | 62 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.46e-04 | 2 | 62 | 2 | HP:0001042 | |
| HumanPheno | Abnormal toe phalanx morphology | 1.54e-04 | 130 | 62 | 8 | HP:0010161 | |
| HumanPheno | Facial hypertrichosis | ADAMTS3 EBF3 CREBBP BPTF ARID1B CSNK2A1 SMARCA2 PACS2 PAX3 EP300 | 1.60e-04 | 206 | 62 | 10 | HP:0002219 |
| HumanPheno | Thin upper lip vermilion | EBF3 ARID1A CREBBP BPTF ARID1B KMT2D CSNK2A1 MED12L SMARCA2 SMARCA4 PACS2 NONO EP300 | 1.68e-04 | 339 | 62 | 13 | HP:0000219 |
| HumanPheno | Thin lips | EBF3 ARID1A CREBBP BPTF ARID1B KMT2D CSNK2A1 MED12L SMARCA2 SMARCA4 PACS2 NONO EP300 | 1.68e-04 | 339 | 62 | 13 | HP:0000213 |
| HumanPheno | Abnormal hand morphology | FLI1 TMEM67 GALNS COL17A1 COMP EBF3 RREB1 ARID1A CREBBP SH2B1 BPTF ARID1B KMT2D GLI1 CSNK2A1 PITX1 MED25 SMARCA2 SMARCA4 PACS2 PAX3 COASY EN1 NONO EP300 WNK3 | 1.74e-04 | 1082 | 62 | 26 | HP:0005922 |
| HumanPheno | Abnormal toe morphology | FLI1 TMEM67 COL12A1 ADAMTS3 EBF3 RREB1 ARID1A CREBBP SH2B1 BPTF ARID1B KMT2D GLI1 CSNK2A1 PITX1 MED25 SMARCA2 SMARCA4 PAX3 EN1 NONO EP300 TBX2 | 1.79e-04 | 893 | 62 | 23 | HP:0001780 |
| HumanPheno | Broad philtrum | 1.91e-04 | 45 | 62 | 5 | HP:0000289 | |
| HumanPheno | Downslanted palpebral fissures | FLI1 EBF3 RREB1 CREBBP BPTF ARID1B KMT2D BRPF1 PITX1 MED25 MED12L SMARCA2 PACS2 PAX3 NONO EP300 | 2.06e-04 | 497 | 62 | 16 | HP:0000494 |
| HumanPheno | Abnormal nasal bridge morphology | FLI1 TMEM67 ADAMTS3 EBF3 RBL2 PCLO U2AF2 RREB1 ARID1A CREBBP SH2B1 BPTF ARID1B KMT2D CSNK2A1 BRPF1 PITX1 MED12L SMARCA2 SMARCA4 PACS2 PAX3 NONO EP300 TBX2 | 2.10e-04 | 1029 | 62 | 25 | HP:0000422 |
| HumanPheno | Abnormal distal phalanx morphology of finger | 2.19e-04 | 174 | 62 | 9 | HP:0009832 | |
| HumanPheno | Abnormality of the frontal hairline | EBF3 RBL2 ARID1A CREBBP SH2B1 ARID1B SMARCA2 SMARCA4 EP300 TBX2 | 2.28e-04 | 215 | 62 | 10 | HP:0000599 |
| HumanPheno | Abnormal scalp morphology | FLI1 COL17A1 SASH1 EBF3 RBL2 ARID1A CREBBP SH2B1 ARID1B KMT2D MED25 SMARCA2 SMARCA4 EP300 TBX2 | 2.33e-04 | 450 | 62 | 15 | HP:0001965 |
| HumanPheno | Joint hypermobility | COL12A1 GALNS COMP SOBP RREB1 ARID1A CREBBP ARID1B KMT2D OTX2 CSNK2A1 BRPF1 SMARCA2 SMARCA4 EN1 NONO EP300 | 2.37e-04 | 557 | 62 | 17 | HP:0001382 |
| HumanPheno | Chiari type I malformation | 2.60e-04 | 48 | 62 | 5 | HP:0007099 | |
| HumanPheno | Wide nasal bridge | FLI1 ADAMTS3 EBF3 RBL2 RREB1 CREBBP BPTF ARID1B KMT2D CSNK2A1 BRPF1 SMARCA2 SMARCA4 PACS2 PAX3 EP300 | 2.66e-04 | 508 | 62 | 16 | HP:0000431 |
| HumanPheno | Abnormal finger morphology | FLI1 TMEM67 COL12A1 COL17A1 COMP ADAMTS3 EBF3 RREB1 ARID1A CREBBP SH2B1 BPTF ARID1B KMT2D GLI1 CSNK2A1 PITX1 MED25 MED12L SMARCA2 SMARCA4 PACS2 DNAAF6 PAX3 COASY EN1 NONO EP300 WNK3 TBX2 | 2.76e-04 | 1385 | 62 | 30 | HP:0001167 |
| HumanPheno | Abnormal posterior cranial fossa morphology | TMEM67 EBF3 ARID1A CREBBP SH2B1 ARID1B PITX1 SMARCA4 PACS2 EP300 | 2.85e-04 | 221 | 62 | 10 | HP:0000932 |
| HumanPheno | Inguinal hernia | FLI1 TMEM67 GALNS RREB1 ARID1A CREBBP ARID1B KMT2D CSNK2A1 MED25 SMARCA2 WNK3 | 3.03e-04 | 312 | 62 | 12 | HP:0000023 |
| HumanPheno | Abnormal patella morphology | 3.16e-04 | 109 | 62 | 7 | HP:0003045 | |
| HumanPheno | Abnormality of upper lip vermillion | EBF3 ARID1A CREBBP BPTF ARID1B KMT2D CSNK2A1 MED25 MED12L SMARCA2 SMARCA4 PACS2 PAX3 NONO EP300 | 3.27e-04 | 464 | 62 | 15 | HP:0011339 |
| HumanPheno | Wide nasal base | 3.27e-04 | 28 | 62 | 4 | HP:0012810 | |
| HumanPheno | Clinodactyly | FLI1 EBF3 ARID1A CREBBP BPTF ARID1B KMT2D CSNK2A1 PITX1 MED25 SMARCA2 SMARCA4 PACS2 PAX3 NONO EP300 WNK3 | 3.41e-04 | 574 | 62 | 17 | HP:0030084 |
| HumanPheno | Diagnostic behavioral phenotype | FLI1 U2AF2 POU3F3 ST3GAL3 RREB1 ARID1A CREBBP SH2B1 ARID1B KMT2D USF3 OTX2 RBM12 MED12L SMARCA2 SMARCA4 PACS2 NONO EP300 TBX2 | 3.41e-04 | 747 | 62 | 20 | HP:0025783 |
| HumanPheno | Abnormal nostril morphology | FLI1 TMEM67 ADAMTS3 EBF3 ARID1A CREBBP BPTF ARID1B KMT2D OTX2 CSNK2A1 MED25 MED12L SMARCA2 SMARCA4 PAX3 TBX2 | 3.48e-04 | 575 | 62 | 17 | HP:0005288 |
| HumanPheno | Hypoplasia of the phalanges of the toes | 3.49e-04 | 12 | 62 | 3 | HP:0010746 | |
| HumanPheno | Ptosis | FLI1 TMEM67 U2AF2 RREB1 ARID1A CREBBP BPTF ARID1B KMT2D ZFHX4 CSNK2A1 BRPF1 MED25 MED12L SMARCA2 SMARCA4 PACS2 PAX3 EP300 WNK3 | 3.87e-04 | 754 | 62 | 20 | HP:0000508 |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 4.16e-04 | 53 | 62 | 5 | HP:0009906 | |
| HumanPheno | Abnormal nasal base norphology | 4.30e-04 | 30 | 62 | 4 | HP:0012808 | |
| HumanPheno | Overfolded helix | 4.33e-04 | 82 | 62 | 6 | HP:0000396 | |
| HumanPheno | Laryngeal cartilage malformation | 4.34e-04 | 3 | 62 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 4.34e-04 | 3 | 62 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 4.34e-04 | 3 | 62 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 4.34e-04 | 3 | 62 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 4.34e-04 | 3 | 62 | 2 | HP:0005322 | |
| HumanPheno | Short phalanx of the 5th toe | 4.34e-04 | 3 | 62 | 2 | HP:0100368 | |
| HumanPheno | Keloids | 4.50e-04 | 13 | 62 | 3 | HP:0010562 | |
| HumanPheno | Thin vermilion border | EBF3 ARID1A CREBBP BPTF ARID1B KMT2D GLI1 CSNK2A1 MED12L SMARCA2 SMARCA4 PACS2 NONO EP300 | 5.39e-04 | 433 | 62 | 14 | HP:0000233 |
| HumanPheno | Abnormality of the scalp hair | COL17A1 SASH1 EBF3 RBL2 ARID1A CREBBP SH2B1 ARID1B KMT2D MED25 SMARCA2 SMARCA4 EP300 TBX2 | 5.39e-04 | 433 | 62 | 14 | HP:0100037 |
| HumanPheno | Strabismus | FLI1 TMEM67 COL12A1 ADAMTS3 EBF3 SOBP RBL2 U2AF2 RREB1 ARID1A CREBBP BPTF ARID1B KMT2D OTX2 ASCL1 GLI1 BRPF1 MED25 MED12L SMARCA4 PACS2 PAX3 NONO EP300 WNK3 | 5.51e-04 | 1159 | 62 | 26 | HP:0000486 |
| HumanPheno | Intestinal malrotation | 5.59e-04 | 157 | 62 | 8 | HP:0002566 | |
| HumanPheno | Hypoplastic fifth fingernail | 5.68e-04 | 14 | 62 | 3 | HP:0008398 | |
| HumanPheno | Abnormal skull base morphology | TMEM67 EBF3 ARID1A CREBBP SH2B1 ARID1B PITX1 SMARCA4 PACS2 EP300 | 5.89e-04 | 242 | 62 | 10 | HP:0002693 |
| HumanPheno | Broad toe | 5.96e-04 | 87 | 62 | 6 | HP:0001837 | |
| HumanPheno | Abnormality of the philtrum | FLI1 ADAMTS3 EBF3 PCLO U2AF2 RREB1 ARID1A CREBBP BPTF ARID1B KMT2D BRPF1 MED25 MED12L SMARCA2 SMARCA4 PAX3 NONO EP300 | 6.80e-04 | 726 | 62 | 19 | HP:0000288 |
| HumanPheno | Epicanthus inversus | 7.04e-04 | 15 | 62 | 3 | HP:0000537 | |
| HumanPheno | Abnormality of the hairline | EBF3 RBL2 ARID1A CREBBP SH2B1 ARID1B KMT2D SMARCA2 SMARCA4 EP300 TBX2 | 7.08e-04 | 294 | 62 | 11 | HP:0009553 |
| HumanPheno | Abnormally folded helix | 7.14e-04 | 90 | 62 | 6 | HP:0008544 | |
| HumanPheno | Brachydactyly | FLI1 TMEM67 COMP EBF3 ARID1A CREBBP BPTF ARID1B KMT2D USF3 GLI1 CSNK2A1 PITX1 MED25 SMARCA2 SMARCA4 PAX3 EP300 | 7.23e-04 | 670 | 62 | 18 | HP:0001156 |
| HumanPheno | Abnormal upper lip morphology | FLI1 ADAMTS3 EBF3 PCLO U2AF2 RREB1 ARID1A CREBBP BPTF ARID1B KMT2D OTX2 CSNK2A1 BRPF1 PITX1 MED25 MED12L SMARCA2 SMARCA4 PACS2 PAX3 NONO EP300 | 7.29e-04 | 980 | 62 | 23 | HP:0000177 |
| HumanPheno | Short digit | FLI1 TMEM67 COMP EBF3 ARID1A CREBBP BPTF ARID1B KMT2D USF3 GLI1 CSNK2A1 PITX1 MED25 SMARCA2 SMARCA4 PAX3 EP300 | 7.49e-04 | 672 | 62 | 18 | HP:0011927 |
| HumanPheno | Epicanthus | FLI1 ADAMTS3 EBF3 POU3F3 RREB1 CREBBP BPTF ARID1B KMT2D CSNK2A1 MED25 SMARCA2 PAX3 NONO EP300 WNK3 TBX2 | 7.53e-04 | 614 | 62 | 17 | HP:0000286 |
| HumanPheno | Autistic behavior | U2AF2 POU3F3 ST3GAL3 RREB1 ARID1A CREBBP SH2B1 ARID1B KMT2D USF3 OTX2 MED12L SMARCA2 SMARCA4 PACS2 NONO EP300 TBX2 | 8.34e-04 | 678 | 62 | 18 | HP:0000729 |
| HumanPheno | Abnormality of globe location | FLI1 TMEM67 ADAMTS3 EBF3 RBL2 PCLO RREB1 CREBBP SH2B1 BPTF ARID1B KMT2D OTX2 CSNK2A1 BRPF1 PITX1 MED25 MED12L SMARCA2 PACS2 PAX3 NONO EP300 WNK3 TBX2 | 8.41e-04 | 1122 | 62 | 25 | HP:0100886 |
| HumanPheno | Trichiasis | 8.61e-04 | 4 | 62 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 8.61e-04 | 4 | 62 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 8.61e-04 | 4 | 62 | 2 | HP:0011087 | |
| HumanPheno | Aplasia of the thymus | 8.61e-04 | 4 | 62 | 2 | HP:0005359 | |
| HumanPheno | Widened distal phalanges | 8.61e-04 | 4 | 62 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 8.61e-04 | 4 | 62 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 8.61e-04 | 4 | 62 | 2 | HP:0031207 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 8.61e-04 | 4 | 62 | 2 | HP:0010343 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | COMP EBF3 CREBBP BPTF ARID1B KMT2D CSNK2A1 PITX1 MED25 SMARCA2 PACS2 PAX3 COASY NONO EP300 WNK3 | 8.64e-04 | 564 | 62 | 16 | HP:0009484 |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 8.76e-04 | 36 | 62 | 4 | HP:0009617 | |
| HumanPheno | Hydrocele testis | 8.76e-04 | 36 | 62 | 4 | HP:0000034 | |
| HumanPheno | Long eyelashes | 8.76e-04 | 129 | 62 | 7 | HP:0000527 | |
| HumanPheno | Thin corpus callosum | FLI1 TMEM67 RBL2 PCLO U2AF2 POU3F3 ARID1A CREBBP ARID1B KMT2D OTX2 BRPF1 PITX1 MED25 MED12L SMARCA2 SMARCA4 COASY NONO EP300 TP73 | 9.27e-04 | 868 | 62 | 21 | HP:0033725 |
| HumanPheno | Abnormal hallux morphology | 9.38e-04 | 212 | 62 | 9 | HP:0001844 | |
| HumanPheno | Abnormal conjugate eye movement | FLI1 TMEM67 COL12A1 ADAMTS3 EBF3 SOBP RBL2 U2AF2 RREB1 ARID1A CREBBP BPTF ARID1B KMT2D OTX2 ASCL1 GLI1 BRPF1 MED25 MED12L SMARCA4 PACS2 PAX3 NONO EP300 WNK3 | 9.41e-04 | 1198 | 62 | 26 | HP:0000549 |
| HumanPheno | Short phalanx of finger | FLI1 COMP ARID1A CREBBP BPTF ARID1B KMT2D GLI1 MED25 SMARCA2 EP300 | 9.88e-04 | 306 | 62 | 11 | HP:0009803 |
| HumanPheno | Abnormal corpus callosum morphology | FLI1 TMEM67 RBL2 PCLO U2AF2 POU3F3 ARID1A CREBBP ARID1B KMT2D OTX2 BRPF1 PITX1 MED25 MED12L SMARCA2 SMARCA4 PACS2 COASY NONO EP300 TP73 | 1.00e-03 | 937 | 62 | 22 | HP:0001273 |
| HumanPheno | Aggressive behavior | TMEM67 EBF3 RBL2 ARID1A CREBBP SH2B1 BPTF ARID1B MED25 MED12L SMARCA2 SMARCA4 PACS2 NONO EP300 | 1.01e-03 | 516 | 62 | 15 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | TMEM67 EBF3 RBL2 ARID1A CREBBP SH2B1 BPTF ARID1B MED25 MED12L SMARCA2 SMARCA4 PACS2 NONO EP300 | 1.01e-03 | 516 | 62 | 15 | HP:0006919 |
| HumanPheno | Premature thelarche | 1.03e-03 | 17 | 62 | 3 | HP:0010314 | |
| HumanPheno | Oral aversion | 1.03e-03 | 17 | 62 | 3 | HP:0012523 | |
| HumanPheno | Single transverse palmar crease | 1.04e-03 | 215 | 62 | 9 | HP:0000954 | |
| MousePheno | open neural tube | TMEM67 SUPT20H MDFI ARID1A CREBBP PTK7 OTX2 RBM12 ZC3H4 PAX3 EP300 | 5.70e-06 | 226 | 125 | 11 | MP:0000929 |
| MousePheno | abnormal head morphology | AMBN TMEM67 NCOA3 SALL3 ADAMTS3 MAZ RREB1 KLF4 CREBBP PTK7 EBF2 KMT2D OTX2 ZFHX4 ASCL1 NFIC CSNK2A1 PITX1 SMARCA4 CHRD PAX3 EP300 TP73 TBX2 | 4.75e-05 | 1120 | 125 | 24 | MP:0000432 |
| MousePheno | abnormal mesoderm development | 5.11e-05 | 74 | 125 | 6 | MP:0001680 | |
| MousePheno | abnormal facial morphology | AMBN NCOA3 SALL3 ADAMTS3 RREB1 KLF4 CREBBP PTK7 EBF2 KMT2D OTX2 ZFHX4 ASCL1 NFIC CSNK2A1 PITX1 CHRD PAX3 EP300 TP73 TBX2 | 5.32e-05 | 910 | 125 | 21 | MP:0003743 |
| MousePheno | abnormal gastrulation | SUPT20H RBL2 MDFI ARID1A STRIP1 PTK7 BPTF OTX2 TLN1 CHRD CSTF2 PAX3 NONO EP300 | 7.67e-05 | 469 | 125 | 14 | MP:0001695 |
| Domain | Bromodomain_CS | 3.38e-08 | 26 | 141 | 6 | IPR018359 | |
| Domain | Nuc_rcpt_coact | 4.61e-08 | 6 | 141 | 4 | IPR009110 | |
| Domain | MeCpG-bd_2/3_C_dom | 1.07e-07 | 7 | 141 | 4 | IPR025884 | |
| Domain | MBD2/MBD3_p55-bd | 1.07e-07 | 7 | 141 | 4 | IPR032343 | |
| Domain | MBDa | 1.07e-07 | 7 | 141 | 4 | PF16564 | |
| Domain | MBD_C | 1.07e-07 | 7 | 141 | 4 | PF14048 | |
| Domain | HOMEOBOX_1 | POU6F2 ADNP2 POU3F3 OTP OTX2 ZFHX4 PITX1 ZFHX3 PAX3 EN1 PRRX2 NOBOX | 2.37e-07 | 236 | 141 | 12 | PS00027 |
| Domain | HOX | POU6F2 ADNP2 POU3F3 OTP OTX2 ZFHX4 PITX1 ZFHX3 PAX3 EN1 PRRX2 NOBOX | 2.48e-07 | 237 | 141 | 12 | SM00389 |
| Domain | HOMEOBOX_2 | POU6F2 ADNP2 POU3F3 OTP OTX2 ZFHX4 PITX1 ZFHX3 PAX3 EN1 PRRX2 NOBOX | 2.72e-07 | 239 | 141 | 12 | PS50071 |
| Domain | Homeobox_dom | POU6F2 ADNP2 POU3F3 OTP OTX2 ZFHX4 PITX1 ZFHX3 PAX3 EN1 PRRX2 NOBOX | 2.72e-07 | 239 | 141 | 12 | IPR001356 |
| Domain | BROMODOMAIN_1 | 3.19e-07 | 37 | 141 | 6 | PS00633 | |
| Domain | Bromodomain | 3.76e-07 | 38 | 141 | 6 | PF00439 | |
| Domain | BROMODOMAIN_2 | 6.02e-07 | 41 | 141 | 6 | PS50014 | |
| Domain | Bromodomain | 6.98e-07 | 42 | 141 | 6 | IPR001487 | |
| Domain | BROMO | 6.98e-07 | 42 | 141 | 6 | SM00297 | |
| Domain | - | 6.98e-07 | 42 | 141 | 6 | 1.20.920.10 | |
| Domain | Homeodomain-like | POU6F2 EP400 ADNP2 POU3F3 OTP OTX2 ZFHX4 PITX1 ZFHX3 PAX3 EN1 PRRX2 NOBOX | 1.44e-06 | 332 | 141 | 13 | IPR009057 |
| Domain | Homeobox | POU6F2 POU3F3 OTP OTX2 ZFHX4 PITX1 ZFHX3 PAX3 EN1 PRRX2 NOBOX | 1.66e-06 | 234 | 141 | 11 | PF00046 |
| Domain | HSA | 1.68e-06 | 4 | 141 | 3 | SM00573 | |
| Domain | HSA | 1.68e-06 | 4 | 141 | 3 | PS51204 | |
| Domain | HSA_dom | 1.68e-06 | 4 | 141 | 3 | IPR014012 | |
| Domain | HSA | 1.68e-06 | 4 | 141 | 3 | PF07529 | |
| Domain | RRM | U2AF2 RBM20 MYEF2 RBM12 TNRC6A CSTF2 RBM46 RBM47 NONO CSTF2T | 5.98e-06 | 217 | 141 | 10 | SM00360 |
| Domain | RRM_dom | U2AF2 RBM20 MYEF2 RBM12 TNRC6A CSTF2 RBM46 RBM47 NONO CSTF2T | 8.89e-06 | 227 | 141 | 10 | IPR000504 |
| Domain | RRM | U2AF2 RBM20 MYEF2 RBM12 TNRC6A CSTF2 RBM46 RBM47 NONO CSTF2T | 9.97e-06 | 230 | 141 | 10 | PS50102 |
| Domain | - | POU6F2 POU3F3 OTP OTX2 ZFHX4 PITX1 ZFHX3 PAX3 EN1 PRRX2 NOBOX | 1.03e-05 | 283 | 141 | 11 | 1.10.10.60 |
| Domain | Homeobox_CS | 1.20e-05 | 186 | 141 | 9 | IPR017970 | |
| Domain | - | U2AF2 RBM20 MYEF2 RBM12 TNRC6A CSTF2 RBM46 RBM47 NONO CSTF2T | 1.67e-05 | 244 | 141 | 10 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | U2AF2 RBM20 MYEF2 RBM12 TNRC6A CSTF2 RBM46 RBM47 NONO CSTF2T | 2.69e-05 | 258 | 141 | 10 | IPR012677 |
| Domain | Collagen | 4.46e-05 | 85 | 141 | 6 | IPR008160 | |
| Domain | Collagen | 4.46e-05 | 85 | 141 | 6 | PF01391 | |
| Domain | Nuc_rcpt_coact_CREBbp | 5.66e-05 | 2 | 141 | 2 | IPR014744 | |
| Domain | BCL9 | 5.66e-05 | 2 | 141 | 2 | PF11502 | |
| Domain | ZnF_TAZ | 5.66e-05 | 2 | 141 | 2 | SM00551 | |
| Domain | Gln-Leu-Gln_QLQ | 5.66e-05 | 2 | 141 | 2 | IPR014978 | |
| Domain | - | 5.66e-05 | 2 | 141 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 5.66e-05 | 2 | 141 | 2 | IPR010303 | |
| Domain | - | 5.66e-05 | 2 | 141 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 5.66e-05 | 2 | 141 | 2 | PF09030 | |
| Domain | SnAC | 5.66e-05 | 2 | 141 | 2 | PF14619 | |
| Domain | QLQ | 5.66e-05 | 2 | 141 | 2 | SM00951 | |
| Domain | zf-TAZ | 5.66e-05 | 2 | 141 | 2 | PF02135 | |
| Domain | ZF_TAZ | 5.66e-05 | 2 | 141 | 2 | PS50134 | |
| Domain | CSTF2_hinge | 5.66e-05 | 2 | 141 | 2 | PF14327 | |
| Domain | QLQ | 5.66e-05 | 2 | 141 | 2 | PS51666 | |
| Domain | CSTF_C | 5.66e-05 | 2 | 141 | 2 | PF14304 | |
| Domain | BAF250/Osa | 5.66e-05 | 2 | 141 | 2 | IPR021906 | |
| Domain | KAT11 | 5.66e-05 | 2 | 141 | 2 | SM01250 | |
| Domain | Znf_TAZ | 5.66e-05 | 2 | 141 | 2 | IPR000197 | |
| Domain | KIX | 5.66e-05 | 2 | 141 | 2 | PF02172 | |
| Domain | Bcl-9 | 5.66e-05 | 2 | 141 | 2 | IPR015668 | |
| Domain | SnAC | 5.66e-05 | 2 | 141 | 2 | SM01314 | |
| Domain | BCL9_beta-catenin-bd_dom | 5.66e-05 | 2 | 141 | 2 | IPR024670 | |
| Domain | BAF250_C | 5.66e-05 | 2 | 141 | 2 | IPR033388 | |
| Domain | HAT_KAT11 | 5.66e-05 | 2 | 141 | 2 | PF08214 | |
| Domain | KIX | 5.66e-05 | 2 | 141 | 2 | PS50952 | |
| Domain | CSTF2_hinge | 5.66e-05 | 2 | 141 | 2 | IPR025742 | |
| Domain | CBP_P300_HAT | 5.66e-05 | 2 | 141 | 2 | IPR031162 | |
| Domain | DUF902 | 5.66e-05 | 2 | 141 | 2 | PF06001 | |
| Domain | SnAC | 5.66e-05 | 2 | 141 | 2 | IPR029295 | |
| Domain | - | 5.66e-05 | 2 | 141 | 2 | 1.10.246.20 | |
| Domain | BAF250_C | 5.66e-05 | 2 | 141 | 2 | PF12031 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 5.66e-05 | 2 | 141 | 2 | IPR013178 | |
| Domain | QLQ | 5.66e-05 | 2 | 141 | 2 | PF08880 | |
| Domain | KIX_dom | 5.66e-05 | 2 | 141 | 2 | IPR003101 | |
| Domain | CSTF_C | 5.66e-05 | 2 | 141 | 2 | IPR026896 | |
| Domain | CBP_P300_HAT | 5.66e-05 | 2 | 141 | 2 | PS51727 | |
| Domain | DUF1518 | 1.69e-04 | 3 | 141 | 2 | PF07469 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 1.69e-04 | 3 | 141 | 2 | IPR014920 | |
| Domain | SRC-1 | 1.69e-04 | 3 | 141 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 1.69e-04 | 3 | 141 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 1.69e-04 | 3 | 141 | 2 | IPR017426 | |
| Domain | - | 1.69e-04 | 3 | 141 | 2 | 4.10.630.10 | |
| Domain | DUF1518 | 1.69e-04 | 3 | 141 | 2 | IPR010011 | |
| Domain | DUF1518 | 1.69e-04 | 3 | 141 | 2 | SM01151 | |
| Domain | SRC-1 | 1.69e-04 | 3 | 141 | 2 | PF08832 | |
| Domain | Nuc_rec_co-act | 1.69e-04 | 3 | 141 | 2 | PF08815 | |
| Domain | OAR | 1.79e-04 | 15 | 141 | 3 | PF03826 | |
| Domain | RRM_1 | 1.85e-04 | 208 | 141 | 8 | PF00076 | |
| Domain | OAR | 2.19e-04 | 16 | 141 | 3 | PS50803 | |
| Domain | OAR_dom | 2.19e-04 | 16 | 141 | 3 | IPR003654 | |
| Domain | HLH | 2.50e-04 | 116 | 141 | 6 | SM00353 | |
| Domain | COE | 3.36e-04 | 4 | 141 | 2 | PS01345 | |
| Domain | Transcription_factor_COE | 3.36e-04 | 4 | 141 | 2 | IPR003523 | |
| Domain | COE_HLH | 3.36e-04 | 4 | 141 | 2 | IPR032201 | |
| Domain | COE_DBD | 3.36e-04 | 4 | 141 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 3.36e-04 | 4 | 141 | 2 | IPR018350 | |
| Domain | COE1_HLH | 3.36e-04 | 4 | 141 | 2 | PF16423 | |
| Domain | COE1_DBD | 3.36e-04 | 4 | 141 | 2 | PF16422 | |
| Domain | HnRNP_R/Q_splicing_fac | 5.58e-04 | 5 | 141 | 2 | IPR006535 | |
| Domain | INTEGRASE | 5.58e-04 | 5 | 141 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 5.58e-04 | 5 | 141 | 2 | IPR001584 | |
| Domain | TSPN | 6.68e-04 | 23 | 141 | 3 | SM00210 | |
| Domain | BRK | 8.32e-04 | 6 | 141 | 2 | SM00592 | |
| Domain | BRK_domain | 8.32e-04 | 6 | 141 | 2 | IPR006576 | |
| Domain | BRK | 8.32e-04 | 6 | 141 | 2 | PF07533 | |
| Domain | Znf_U1 | 1.33e-03 | 29 | 141 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 1.33e-03 | 29 | 141 | 3 | SM00451 | |
| Domain | SNF2_N | 1.78e-03 | 32 | 141 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.78e-03 | 32 | 141 | 3 | PF00176 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | SUPT20H EP400 ARID1A CREBBP ARID1B KMT2D BRPF1 SMARCA2 SMARCA4 NCOA1 PAX3 SAP130 EP300 | 4.24e-08 | 272 | 97 | 13 | M29619 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A5 FLI1 NCOA3 MED30 COL5A3 POU3F3 RFX6 ARID1A KLF4 CREBBP MEF2A EBF2 ARID1B KMT2D OTX2 CSNK2A1 TLN1 SS18L1 NCAN TNRC6A MED25 SMARCA2 SMARCA4 NCOA1 PAX3 EP300 TUBAL3 TBX2 NOBOX | 5.52e-08 | 1432 | 97 | 29 | M509 |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.78e-07 | 37 | 97 | 6 | M27797 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.34e-07 | 22 | 97 | 5 | MM1370 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | ARID1A CREBBP ARID1B SS18L1 TNRC6A SMARCA2 SMARCA4 PAX3 TBX2 | 4.12e-07 | 137 | 97 | 9 | M48232 |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.33e-07 | 24 | 97 | 5 | M13404 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 8.16e-07 | 26 | 97 | 5 | MM14793 | |
| Pathway | REACTOME_ADIPOGENESIS | 8.64e-07 | 110 | 97 | 8 | M48259 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | SALL3 EP400 RBL2 KLF4 CREBBP KMT2D OTX2 SMARCA2 SMARCA4 NCOA1 EP300 NOBOX | 1.02e-06 | 301 | 97 | 12 | MM15983 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.72e-06 | 84 | 97 | 7 | M1008 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.72e-06 | 61 | 97 | 6 | MM14637 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.96e-06 | 95 | 97 | 7 | M48268 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | ARID1A CREBBP ARID1B KMT2D CSNK2A1 TNRC6A SMARCA2 SMARCA4 EP300 TP73 | 5.22e-06 | 237 | 97 | 10 | M27786 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 5.91e-06 | 142 | 97 | 8 | M27233 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.46e-06 | 67 | 97 | 6 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 8.56e-06 | 41 | 97 | 5 | MM15538 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | ARID1A POLR1G ARID1B KMT2D SS18L1 SMARCA2 SMARCA4 SPOCD1 SAP130 EP300 | 9.60e-06 | 254 | 97 | 10 | M27131 |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 9.67e-06 | 42 | 97 | 5 | M48237 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.22e-05 | 44 | 97 | 5 | M27812 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.35e-05 | 76 | 97 | 6 | MM14573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.72e-05 | 8 | 97 | 3 | M22058 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.88e-05 | 48 | 97 | 5 | M288 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.55e-05 | 90 | 97 | 6 | M631 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.78e-05 | 91 | 97 | 6 | M27101 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.38e-05 | 29 | 97 | 4 | M48076 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 5.03e-05 | 30 | 97 | 4 | M207 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 5.03e-05 | 30 | 97 | 4 | M39580 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 5.03e-05 | 30 | 97 | 4 | MM15831 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 5.42e-05 | 97 | 97 | 6 | M48262 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 5.75e-05 | 31 | 97 | 4 | M39522 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.10e-05 | 61 | 97 | 5 | M27103 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 7.69e-05 | 64 | 97 | 5 | M26953 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 8.34e-05 | 34 | 97 | 4 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 9.36e-05 | 35 | 97 | 4 | M47969 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 1.35e-04 | 15 | 97 | 3 | M119 | |
| Pathway | PID_E2F_PATHWAY | 1.44e-04 | 73 | 97 | 5 | M40 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.54e-04 | 74 | 97 | 5 | M160 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.61e-04 | 118 | 97 | 6 | M27316 | |
| Pathway | PID_HNF3A_PATHWAY | 2.32e-04 | 44 | 97 | 4 | M285 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.39e-04 | 18 | 97 | 3 | M26942 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.75e-04 | 46 | 97 | 4 | M198 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.99e-04 | 47 | 97 | 4 | M7946 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 3.12e-04 | 86 | 97 | 5 | M2642 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 3.31e-04 | 20 | 97 | 3 | M497 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.31e-04 | 20 | 97 | 3 | M27881 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 3.31e-04 | 20 | 97 | 3 | MM15469 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.81e-04 | 50 | 97 | 4 | MM14796 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 3.84e-04 | 21 | 97 | 3 | M39593 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED30 WDR33 RBL2 U2AF2 ARID1A KLF4 CREBBP ARID1B KMT2D CSNK2A1 BRPF1 TNRC6A MED25 SMARCA2 SMARCA4 CSTF2 ZFHX3 EP300 CSTF2T NOTCH4 TP73 | 4.06e-04 | 1387 | 97 | 21 | M734 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 4.38e-04 | 142 | 97 | 6 | M48257 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.62e-04 | 5 | 97 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 4.62e-04 | 5 | 97 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 4.62e-04 | 5 | 97 | 2 | M48023 | |
| Pathway | KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 4.62e-04 | 5 | 97 | 2 | M48983 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 4.62e-04 | 5 | 97 | 2 | M27228 | |
| Pathway | PID_AR_TF_PATHWAY | 4.76e-04 | 53 | 97 | 4 | M151 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.76e-04 | 53 | 97 | 4 | MM14566 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 6.50e-04 | 153 | 97 | 6 | MM15522 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 6.90e-04 | 6 | 97 | 2 | M22062 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 7.69e-04 | 158 | 97 | 6 | MM14791 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 7.95e-04 | 159 | 97 | 6 | M39373 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 8.66e-04 | 62 | 97 | 4 | MM15426 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 9.62e-04 | 7 | 97 | 2 | MM1573 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 9.62e-04 | 7 | 97 | 2 | M27087 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 9.62e-04 | 7 | 97 | 2 | MM14765 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.01e-03 | 29 | 97 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.01e-03 | 29 | 97 | 3 | MM15444 | |
| Pathway | PID_RB_1PATHWAY | 1.03e-03 | 65 | 97 | 4 | M279 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.03e-03 | 65 | 97 | 4 | M39682 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.07e-03 | 300 | 97 | 8 | M610 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.10e-03 | 66 | 97 | 4 | M27938 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.12e-03 | 233 | 97 | 7 | M27099 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.16e-03 | 67 | 97 | 4 | M27694 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.28e-03 | 8 | 97 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.28e-03 | 8 | 97 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.28e-03 | 8 | 97 | 2 | M46443 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.31e-03 | 175 | 97 | 6 | MM14941 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.37e-03 | 119 | 97 | 5 | M607 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.42e-03 | 120 | 97 | 5 | M48233 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.63e-03 | 9 | 97 | 2 | M47451 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.85e-03 | 76 | 97 | 4 | M27219 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 1.91e-03 | 36 | 97 | 3 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 1.91e-03 | 36 | 97 | 3 | MM14632 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.97e-03 | 330 | 97 | 8 | M7847 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.01e-03 | 258 | 97 | 7 | MM14572 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 2.03e-03 | 10 | 97 | 2 | MM1532 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 2.03e-03 | 10 | 97 | 2 | M27945 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 2.04e-03 | 78 | 97 | 4 | M27234 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 2.07e-03 | 37 | 97 | 3 | M29790 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 2.23e-03 | 80 | 97 | 4 | M223 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.41e-03 | 39 | 97 | 3 | MM14604 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.44e-03 | 82 | 97 | 4 | MM15922 | |
| Pathway | PID_REG_GR_PATHWAY | 2.44e-03 | 82 | 97 | 4 | M115 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.48e-03 | 11 | 97 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.48e-03 | 11 | 97 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.48e-03 | 11 | 97 | 2 | M26924 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 2.48e-03 | 11 | 97 | 2 | M47503 | |
| Pathway | PID_CMYB_PATHWAY | 2.67e-03 | 84 | 97 | 4 | M195 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.79e-03 | 140 | 97 | 5 | M587 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.96e-03 | 12 | 97 | 2 | M7968 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | FLI1 BCL9L NCOA3 EP400 SOBP RREB1 BCL9 ARID1A CREBBP BPTF ARID1B TNRC18 KMT2D OTX2 ZFHX4 NFIC SS18L1 PITX1 NFRKB SMARCA2 SMARCA4 NCOA1 ZFHX3 EP300 TBX2 | 3.33e-23 | 351 | 150 | 25 | 38297188 |
| Pubmed | BCL9L NCOA3 EP400 WDR33 BCL9 ARID1A KLF4 CREBBP MEF2A ARID1B TNRC18 KMT2D RBM12 ZC3H4 NFIC CSNK2A1 NFRKB SMARCA2 SMARCA4 NCOA1 SAP130 | 1.76e-20 | 268 | 150 | 21 | 33640491 | |
| Pubmed | FLI1 BCL9L NCOA3 SUPT20H EP400 WDR33 SOBP MAZ CUL9 PATL1 RREB1 BCL9 ARID1A KLF4 CREBBP MEF2A RBM20 BPTF ARID1B KMT2D RBM12 ZFHX4 NFIC CSNK2A1 SS18L1 PITX1 NFRKB TNRC6A SMARCA2 SMARCA4 CSTF2 NCOA1 ZFHX3 SCAF11 EN1 SAP130 EP300 | 6.74e-19 | 1429 | 150 | 37 | 35140242 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FLI1 NCOA3 POU6F2 NRL EBF3 MAZ ADNP2 POU3F3 TSC22D2 RREB1 KLF4 MEF2A OTP KMT2D USF3 OTX2 ZFHX4 ASCL1 NFIC GLI1 PITX1 NCOA1 ZFHX3 PAX3 EN1 TP73 PRRX2 TBX2 NOBOX | 3.14e-17 | 908 | 150 | 29 | 19274049 |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | POU6F2 SALL3 EBF3 POU3F3 OTP OTX2 ZFHX4 ASCL1 PITX1 ZFHX3 PAX3 EN1 | 5.48e-16 | 75 | 150 | 12 | 37298722 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 SUPT20H EP400 RBL2 PCLO MAZ ADNP2 RREB1 ARID1A CREBBP RBM20 ARID1B TNRC18 KMT2D ZFHX4 NFRKB SMARCA2 SMARCA4 NCOA1 EP300 | 8.61e-16 | 398 | 150 | 20 | 35016035 |
| Pubmed | NCOA3 EP400 BCL9 ARID1A BPTF ARID1B KMT2D NFIC SMARCA2 SMARCA4 SAP130 EP300 | 1.97e-15 | 83 | 150 | 12 | 28794006 | |
| Pubmed | AMBN SLAIN2 SUPT20H EP400 MAZ ADNP2 CUL9 U2AF2 RREB1 ARID1A POLR1G CREBBP MYEF2 BPTF ARID1B ZFHX4 ZC3H4 CSNK2A1 BRPF1 SS18L1 NFRKB TNRC6A SMARCA2 SMARCA4 ZFHX3 SAP130 EP300 TP73 TBX2 | 6.60e-15 | 1116 | 150 | 29 | 31753913 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA3 WDR33 BCL9 ARID1A CREBBP RBM20 MYEF2 NCOA5 ARID1B KMT2D RBM12 NFIC GLI1 TNRC6A SMARCA2 RBM47 NONO SAP130 EP300 | 1.18e-14 | 457 | 150 | 20 | 32344865 |
| Pubmed | SLAIN2 FLI1 NCOA3 EP400 EBF3 RREB1 BCL9 ARID1A CREBBP MEF2A BPTF ARID1B TNRC18 KMT2D RBM12 NFIC CSNK2A1 TLN1 PITX1 NFRKB SMARCA2 SMARCA4 NCOA1 NONO SAP130 EP300 CSTF2T | 2.61e-13 | 1103 | 150 | 27 | 34189442 | |
| Pubmed | EP400 ARID1A CREBBP BPTF ARID1B KMT2D CSNK2A1 BRPF1 SS18L1 SMARCA2 SMARCA4 EP300 | 4.72e-12 | 157 | 150 | 12 | 30186101 | |
| Pubmed | 8.34e-12 | 6 | 150 | 5 | 12504854 | ||
| Pubmed | 8.34e-12 | 6 | 150 | 5 | 18942147 | ||
| Pubmed | 6.93e-11 | 17 | 150 | 6 | 19183483 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 EP400 PATL1 RREB1 BCL9 POLR1G STRIP1 BPTF KMT2D ZC3H4 NFIC CSNK2A1 BRPF1 NFRKB SMARCA2 SMARCA4 PACS2 SCAF11 COASY CSTF2T | 1.69e-10 | 774 | 150 | 20 | 15302935 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA3 U2AF2 ARID1A MYEF2 ARID1B KMT2D RBM12 SMARCA2 NCOA1 ZFHX3 NONO EP300 | 2.43e-10 | 220 | 150 | 12 | 35785414 |
| Pubmed | SLAIN2 EP400 WDR33 ARID1A CREBBP BPTF ARID1B KMT2D TLN1 LPP NFRKB SMARCA4 CSTF2 NONO SAP130 EP300 CSTF2T | 2.86e-10 | 549 | 150 | 17 | 38280479 | |
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 12200431 | ||
| Pubmed | 2.55e-09 | 29 | 150 | 6 | 19279220 | ||
| Pubmed | 4.05e-09 | 15 | 150 | 5 | 23785148 | ||
| Pubmed | 4.05e-09 | 15 | 150 | 5 | 15701600 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 4.95e-09 | 6 | 150 | 4 | 11076796 | |
| Pubmed | 4.95e-09 | 6 | 150 | 4 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 4.95e-09 | 6 | 150 | 4 | 25081545 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EP400 EBF3 MAZ U2AF2 RREB1 ZFHX4 NFIC CSNK2A1 PITX1 SMARCA4 ZFHX3 PAX3 NONO SAP130 TP73 TBX2 | 5.49e-09 | 583 | 150 | 16 | 29844126 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EP400 EBF3 RBL2 CUL9 CREBBP MEF2A SH2B1 MYEF2 BPTF KMT2D ZFHX4 NFIC GLI1 SMARCA4 PAX3 SAP130 EP300 GAA TBX2 | 6.10e-09 | 857 | 150 | 19 | 25609649 |
| Pubmed | 8.28e-09 | 17 | 150 | 5 | 18330926 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FLI1 NCOA3 POU6F2 MED30 TCF19 EBF3 RBL2 CREBBP NCOA5 OTX2 ASCL1 NFIC GLI1 BRPF1 SS18L1 PAX3 EP300 TP73 TBX2 | 8.83e-09 | 877 | 150 | 19 | 20211142 |
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 1.15e-08 | 7 | 150 | 4 | 21079652 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.15e-08 | 7 | 150 | 4 | 9590696 | |
| Pubmed | ZXDC EBF3 POU3F3 ARID1A KLF4 CREBBP MEF2A OTP OTX2 GLI1 BRPF1 SMARCA2 SMARCA4 NCOA1 ZFHX3 KLF17 PAX3 | 1.31e-08 | 709 | 150 | 17 | 22988430 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.98e-08 | 40 | 150 | 6 | 34585037 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | EP400 ADNP2 ARID1A BPTF ARID1B CSNK2A1 SMARCA4 CSNK2A3 SAP130 | 2.01e-08 | 150 | 150 | 9 | 28242625 |
| Pubmed | 2.05e-08 | 20 | 150 | 5 | 20532162 | ||
| Pubmed | 2.25e-08 | 152 | 150 | 9 | 38360978 | ||
| Pubmed | 2.30e-08 | 8 | 150 | 4 | 17475621 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | COL4A5 CDC42BPG POU6F2 SOBP U2AF2 ST3GAL3 PATL1 ARID1A CREBBP MEF2A SH2B1 PTK7 BPTF TNRC18 USF3 NFIC LPP SMARCA2 COBL ZFHX3 SCAF11 CATSPERG SAP130 EP300 | 2.61e-08 | 1489 | 150 | 24 | 28611215 |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 4.41e-08 | 23 | 150 | 5 | 30962207 | |
| Pubmed | 4.41e-08 | 23 | 150 | 5 | 9225980 | ||
| Pubmed | BCL9L NCOA3 PCLO MAZ U2AF2 BCL9 ARID1A CREBBP PITX1 NFRKB CSTF2 EP300 CSTF2T | 4.55e-08 | 425 | 150 | 13 | 24999758 | |
| Pubmed | 4.93e-08 | 78 | 150 | 7 | 28611094 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 5.08e-08 | 167 | 150 | 9 | 20362541 | |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 6.84e-08 | 10 | 150 | 4 | 16751102 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 6.84e-08 | 10 | 150 | 4 | 23129809 | |
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 7.86e-08 | 3 | 150 | 3 | 11823864 | |
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 7.86e-08 | 3 | 150 | 3 | 14716005 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 36464671 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 9590171 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 7.86e-08 | 3 | 150 | 3 | 22426308 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 10648616 | ||
| Pubmed | 1.03e-07 | 130 | 150 | 8 | 19386638 | ||
| Pubmed | 1.07e-07 | 11 | 150 | 4 | 18003620 | ||
| Pubmed | 1.31e-07 | 134 | 150 | 8 | 19030180 | ||
| Pubmed | 1.60e-07 | 12 | 150 | 4 | 11734557 | ||
| Pubmed | 1.60e-07 | 191 | 150 | 9 | 24146773 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.80e-07 | 94 | 150 | 7 | 21542922 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SUPT20H EP400 WDR33 MAZ U2AF2 RREB1 ARID1A POLR1G KLF4 NCOA5 BPTF KMT2D NFIC PITX1 NFRKB SMARCA4 CSTF2 SCAF11 NONO SAP130 EP300 | 1.91e-07 | 1294 | 150 | 21 | 30804502 |
| Pubmed | 2.31e-07 | 13 | 150 | 4 | 17340523 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SUPT20H EP400 EBF3 WDR33 MAZ U2AF2 ARID1A MYEF2 NCOA5 BPTF ARID1B ZC3H4 CSNK2A1 SS18L1 SMARCA4 CSTF2 CATSPERG NONO CSTF2T | 2.35e-07 | 1082 | 150 | 19 | 38697112 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.53e-07 | 146 | 150 | 8 | 23892456 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.69e-07 | 203 | 150 | 9 | 22083510 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 10551785 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 16227615 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 12208951 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 11463834 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 3.14e-07 | 4 | 150 | 3 | 10655477 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 11113179 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 21482710 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 11701890 | ||
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 3.14e-07 | 4 | 150 | 3 | 11988099 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 33481850 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 33589584 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 28398509 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 31906887 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 3.14e-07 | 4 | 150 | 3 | 10469592 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 9194565 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 28863077 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 3.14e-07 | 4 | 150 | 3 | 15170388 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 15449938 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 3.22e-07 | 14 | 150 | 4 | 36289231 | |
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 3.22e-07 | 14 | 150 | 4 | 17641689 | |
| Pubmed | 3.51e-07 | 34 | 150 | 5 | 12086465 | ||
| Pubmed | 3.90e-07 | 65 | 150 | 6 | 26655900 | ||
| Pubmed | 4.27e-07 | 66 | 150 | 6 | 23275444 | ||
| Pubmed | NCOA3 MED30 SUPT20H EP400 POLR1G CREBBP NCOA5 BPTF RBM12 NFIC CSNK2A1 MED25 SMARCA2 SMARCA4 CSTF2 SAP130 EP300 CSTF2T | 4.28e-07 | 1014 | 150 | 18 | 32416067 | |
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 4.37e-07 | 15 | 150 | 4 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 4.37e-07 | 15 | 150 | 4 | 17920018 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 4.37e-07 | 15 | 150 | 4 | 17255939 | |
| Pubmed | 4.37e-07 | 15 | 150 | 4 | 11263494 | ||
| Pubmed | ZXDC NCOA3 SALL3 EBF3 ARID1A KLF4 MEF2A BPTF OTX2 BRPF1 LPP SMARCA2 NCOA1 ZFHX3 KLF17 NOBOX | 4.72e-07 | 808 | 150 | 16 | 20412781 | |
| Pubmed | MED30 EP400 ARID1A CREBBP ARID1B ZC3H4 NFIC SS18L1 MED25 NONO SAP130 EP300 | 7.04e-07 | 453 | 150 | 12 | 29656893 | |
| Pubmed | 7.57e-07 | 17 | 150 | 4 | 11078522 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 7.57e-07 | 17 | 150 | 4 | 12368262 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 17656371 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 17476305 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 11003650 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 18487222 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 7.81e-07 | 5 | 150 | 3 | 12629516 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 12714702 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 25675294 | ||
| Interaction | CRX interactions | FLI1 BCL9L NCOA3 SMAP1 EP400 NRL MDFI RREB1 BCL9 ARID1A CREBBP ARID1B TNRC18 KMT2D OTX2 ZFHX4 NFIC SS18L1 NFRKB SMARCA2 NCOA1 ZFHX3 EP300 | 1.90e-19 | 254 | 138 | 23 | int:CRX |
| Interaction | EGR2 interactions | FLI1 BCL9L NCOA3 EP400 DTX1 RREB1 BCL9 ARID1A CREBBP ARID1B TNRC18 KMT2D ZFHX4 NFIC SS18L1 NFRKB SMARCA2 NCOA1 ZFHX3 EP300 | 3.09e-19 | 171 | 138 | 20 | int:EGR2 |
| Interaction | SP7 interactions | FLI1 BCL9L NCOA3 EP400 WDR33 BCL9 ARID1A CREBBP MEF2A RBM20 ARID1B KMT2D RBM12 ZFHX4 NFIC SS18L1 PITX1 SMARCA2 SMARCA4 NCOA1 SAP130 EP300 | 1.49e-16 | 304 | 138 | 22 | int:SP7 |
| Interaction | PAX7 interactions | FLI1 NCOA3 RREB1 BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC CSNK2A1 SS18L1 SMARCA2 ZFHX3 SAP130 EP300 | 2.79e-16 | 124 | 138 | 16 | int:PAX7 |
| Interaction | SOX7 interactions | NCOA3 ADNP2 RREB1 ARID1A CREBBP RBM20 ARID1B TNRC18 KMT2D ZFHX4 SMARCA2 SMARCA4 NCOA1 EP300 | 3.76e-16 | 82 | 138 | 14 | int:SOX7 |
| Interaction | GSC interactions | FLI1 BCL9L NCOA3 RREB1 BCL9 CREBBP ARID1B TNRC18 KMT2D ZFHX4 NFIC ZFHX3 EP300 | 2.72e-14 | 87 | 138 | 13 | int:GSC |
| Interaction | PAX6 interactions | NCOA3 EP400 RREB1 BCL9 ARID1A CREBBP BPTF ARID1B KMT2D ZFHX4 NFIC CSNK2A1 SS18L1 NFRKB SMARCA2 SMARCA4 ZFHX3 EN1 SAP130 EP300 TP73 | 7.70e-14 | 366 | 138 | 21 | int:PAX6 |
| Interaction | TLE3 interactions | BCL9L NCOA3 EBF3 BCL9 ARID1A CREBBP RBM20 ARID1B TNRC18 KMT2D RBM12 NFIC NFRKB TNRC6A SMARCA4 CSTF2 NCOA1 ZFHX3 EN1 SAP130 EP300 | 1.30e-13 | 376 | 138 | 21 | int:TLE3 |
| Interaction | HNF1B interactions | NCOA3 POU6F2 EP400 BCL9 ARID1A CREBBP BPTF ARID1B KMT2D OTX2 ZFHX4 NFRKB SMARCA2 ZFHX3 SAP130 EP300 | 2.53e-13 | 190 | 138 | 16 | int:HNF1B |
| Interaction | PAX9 interactions | FLI1 BCL9L NCOA3 BCL9 ARID1A KLF4 ARID1B KMT2D ZFHX4 NFIC SMARCA2 ZFHX3 SAP130 EP300 | 2.83e-13 | 130 | 138 | 14 | int:PAX9 |
| Interaction | TEAD1 interactions | RBL2 MAZ RREB1 ARID1A CREBBP MEF2A BPTF ARID1B KMT2D ZFHX4 NFIC SMARCA2 NCOA1 ZFHX3 EP300 | 1.23e-12 | 176 | 138 | 15 | int:TEAD1 |
| Interaction | TBXT interactions | NCOA3 BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC SS18L1 SMARCA2 SMARCA4 SAP130 EP300 | 1.24e-12 | 116 | 138 | 13 | int:TBXT |
| Interaction | SOX10 interactions | NCOA3 POU6F2 POU3F3 BCL9 ARID1A ARID1B KMT2D NFIC SMARCA2 PAX3 EP300 PRRX2 | 1.49e-12 | 92 | 138 | 12 | int:SOX10 |
| Interaction | ETS1 interactions | NCOA3 EP400 ARID1A CREBBP BPTF ARID1B KMT2D SS18L1 NFRKB SMARCA2 SMARCA4 NCOA1 EP300 | 2.14e-12 | 121 | 138 | 13 | int:ETS1 |
| Interaction | AR interactions | CDC42BPG BCL9L NCOA3 EP400 WDR33 U2AF2 POU3F3 RREB1 BCL9 ARID1A KLF4 CREBBP MEF2A MYEF2 ARID1B TNRC18 KMT2D RBM12 ZC3H4 NFIC CSNK2A1 NFRKB MED12L SMARCA2 SMARCA4 NCOA1 ZFHX3 NONO SAP130 EP300 | 4.53e-12 | 992 | 138 | 30 | int:AR |
| Interaction | MYOD1 interactions | NCOA3 EP400 MDFI BCL9 ARID1A CREBBP MEF2A BPTF ARID1B KMT2D SS18L1 SMARCA2 SMARCA4 NCOA1 EP300 | 5.07e-12 | 194 | 138 | 15 | int:MYOD1 |
| Interaction | FEV interactions | NCOA3 SUPT20H EP400 RREB1 BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC SS18L1 NFRKB ZFHX3 EP300 | 9.74e-12 | 203 | 138 | 15 | int:FEV |
| Interaction | NUP35 interactions | BCL9L NCOA3 WDR33 BCL9 ARID1A CREBBP RBM20 MYEF2 NCOA5 ARID1B KMT2D RBM12 NFIC GLI1 TNRC6A SMARCA2 RBM47 NONO SAP130 EP300 | 1.15e-11 | 424 | 138 | 20 | int:NUP35 |
| Interaction | GATA1 interactions | FLI1 MDFI BCL9 ARID1A CREBBP RBM20 ARID1B KMT2D RBM12 PITX1 SMARCA2 SMARCA4 CHRD EP300 | 1.24e-11 | 171 | 138 | 14 | int:GATA1 |
| Interaction | TLX1 interactions | NCOA3 RREB1 BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC CSNK2A1 SMARCA2 ZFHX3 SAP130 EP300 | 1.70e-11 | 175 | 138 | 14 | int:TLX1 |
| Interaction | TBR1 interactions | BCL9L NCOA3 BCL9 ARID1A ARID1B KMT2D ZFHX4 NFIC PITX1 SMARCA2 ZFHX3 EP300 | 1.79e-11 | 113 | 138 | 12 | int:TBR1 |
| Interaction | ALG13 interactions | NCOA3 WDR33 CUL9 BCL9 ARID1A RBM20 NCOA5 ARID1B KMT2D RBM12 PITX1 TNRC6A RBM47 EP300 | 3.10e-11 | 183 | 138 | 14 | int:ALG13 |
| Interaction | KLF3 interactions | EP400 SOBP RREB1 ARID1A BPTF ARID1B KMT2D OTX2 NFIC NFRKB SMARCA2 ZFHX3 SAP130 EP300 TBX2 | 5.11e-11 | 228 | 138 | 15 | int:KLF3 |
| Interaction | SOX9 interactions | NCOA3 EP400 BCL9 ARID1A CREBBP ARID1B KMT2D NFIC SMARCA2 SMARCA4 EP300 | 6.25e-11 | 97 | 138 | 11 | int:SOX9 |
| Interaction | GATA2 interactions | NCOA3 MDFI BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC SMARCA2 SMARCA4 ZFHX3 SAP130 EP300 | 9.54e-11 | 199 | 138 | 14 | int:GATA2 |
| Interaction | PAX8 interactions | NCOA3 BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC SS18L1 SMARCA2 EP300 | 2.74e-10 | 111 | 138 | 11 | int:PAX8 |
| Interaction | HDAC1 interactions | EP400 MBD3L2 RBL2 U2AF2 RREB1 ARID1A POLR1G KLF4 CREBBP MEF2A RBM20 BPTF TNRC18 KMT2D ZFHX4 GLI1 CSNK2A1 TLN1 TNRC6A SMARCA2 SMARCA4 ZFHX3 PAX3 CSNK2A3 NONO SAP130 EP300 CSTF2T TP73 | 3.40e-10 | 1108 | 138 | 29 | int:HDAC1 |
| Interaction | ERG interactions | FLI1 NCOA3 BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC SS18L1 SMARCA2 SMARCA4 NONO EP300 | 4.31e-10 | 223 | 138 | 14 | int:ERG |
| Interaction | FOS interactions | NCOA3 EP400 RBL2 MAZ BCL9 ARID1A CREBBP ARID1B KMT2D NFIC CSNK2A1 SS18L1 SMARCA2 SMARCA4 NCOA1 EP300 | 4.54e-10 | 312 | 138 | 16 | int:FOS |
| Interaction | TP53BP1 interactions | NCOA3 POU6F2 MED30 EP400 RBL2 U2AF2 ARID1A CREBBP MEF2A ARID1B ZC3H4 NFIC SS18L1 PITX1 TNRC6A MED25 NONO SAP130 EP300 TP73 | 6.61e-10 | 533 | 138 | 20 | int:TP53BP1 |
| Interaction | HNF4A interactions | NCOA3 EP400 RREB1 ARID1A CREBBP BPTF ARID1B KMT2D SS18L1 NFRKB SMARCA2 SMARCA4 NCOA1 SAP130 EP300 | 7.03e-10 | 275 | 138 | 15 | int:HNF4A |
| Interaction | FOXI1 interactions | NCOA3 BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 SMARCA2 EP300 CSTF2T | 7.30e-10 | 92 | 138 | 10 | int:FOXI1 |
| Interaction | ETV4 interactions | 1.02e-09 | 69 | 138 | 9 | int:ETV4 | |
| Interaction | SS18L1 interactions | MED30 RFX6 ARID1A CREBBP ARID1B SS18L1 SMARCA2 SMARCA4 CSTF2 EP300 | 1.37e-09 | 98 | 138 | 10 | int:SS18L1 |
| Interaction | SMAD3 interactions | FLI1 NCOA3 U2AF2 ARID1A CREBBP BPTF ARID1B NFIC SS18L1 PITX1 SMARCA4 CHRD NCOA1 ZFHX3 SAP130 EP300 NOTCH4 TP73 | 1.68e-09 | 447 | 138 | 18 | int:SMAD3 |
| Interaction | SMARCA4 interactions | FLI1 EP400 RBL2 ARID1A POLR1G KLF4 CREBBP MYEF2 BPTF ARID1B GLI1 CSNK2A1 SS18L1 SMARCA2 SMARCA4 NCOA1 NONO EP300 | 2.83e-09 | 462 | 138 | 18 | int:SMARCA4 |
| Interaction | LHX2 interactions | BCL9L EP400 RREB1 BCL9 ARID1A ARID1B KMT2D ZFHX4 NFIC SMARCA2 SMARCA4 ZFHX3 | 4.93e-09 | 183 | 138 | 12 | int:LHX2 |
| Interaction | LHX3 interactions | BCL9 ARID1A CREBBP ARID1B KMT2D ZFHX4 NFIC GLI1 CSNK2A1 SS18L1 NFRKB SMARCA2 | 5.57e-09 | 185 | 138 | 12 | int:LHX3 |
| Interaction | NFIX interactions | EP400 RREB1 ARID1A BPTF ARID1B KMT2D OTX2 ZFHX4 NFIC NFRKB SMARCA2 ZFHX3 SAP130 | 5.68e-09 | 227 | 138 | 13 | int:NFIX |
| Interaction | GATA3 interactions | NCOA3 BCL9 ARID1A CREBBP RBM20 ARID1B KMT2D RBM12 ZFHX4 NFIC SMARCA2 EP300 | 6.29e-09 | 187 | 138 | 12 | int:GATA3 |
| Interaction | TLX3 interactions | BCL9L NCOA3 POU6F2 BCL9 ARID1A ARID1B KMT2D OTX2 ZFHX4 NFIC PITX1 SMARCA2 ZFHX3 EP300 | 1.33e-08 | 291 | 138 | 14 | int:TLX3 |
| Interaction | CEBPA interactions | SLAIN2 FLI1 NCOA3 EP400 EBF3 RREB1 BCL9 ARID1A CREBBP MEF2A NCOA5 BPTF ARID1B TNRC18 KMT2D RBM12 NFIC CSNK2A1 TLN1 PITX1 NFRKB SMARCA2 SMARCA4 NCOA1 NONO SAP130 EP300 CSTF2T | 2.02e-08 | 1245 | 138 | 28 | int:CEBPA |
| Interaction | GCM1 interactions | 2.06e-08 | 68 | 138 | 8 | int:GCM1 | |
| Interaction | SMG7 interactions | NCOA3 U2AF2 PATL1 BCL9 ARID1A CREBBP RBM20 ARID1B KMT2D RBM12 ZC3H4 TNRC6A NCOA1 RBM47 | 4.21e-08 | 319 | 138 | 14 | int:SMG7 |
| Interaction | ARID1A interactions | FLI1 ARID1A KLF4 CREBBP BPTF ARID1B NFIC SS18L1 TNRC6A SMARCA2 SMARCA4 NCOA1 EP300 | 5.78e-08 | 276 | 138 | 13 | int:ARID1A |
| Interaction | NFIA interactions | NCOA3 BCL9 ARID1A KLF4 CREBBP ARID1B KMT2D NFIC SMARCA2 EN1 EP300 | 7.14e-08 | 188 | 138 | 11 | int:NFIA |
| Interaction | CIITA interactions | 9.35e-08 | 55 | 138 | 7 | int:CIITA | |
| Interaction | KLF5 interactions | NCOA3 EP400 MAZ BCL9 ARID1A CREBBP RBM20 ARID1B KMT2D SMARCA2 EP300 | 1.04e-07 | 195 | 138 | 11 | int:KLF5 |
| Interaction | CREBBP interactions | NCOA3 RBL2 ARID1A KLF4 CREBBP ARID1B KMT2D NFIC CSNK2A1 SS18L1 MED25 SMARCA2 SMARCA4 NCOA1 NONO EP300 GAA TP73 | 1.49e-07 | 599 | 138 | 18 | int:CREBBP |
| Interaction | E2F5 interactions | 1.52e-07 | 36 | 138 | 6 | int:E2F5 | |
| Interaction | KLF4 interactions | NCOA3 BCL9 ARID1A KLF4 CREBBP ARID1B KMT2D SMARCA2 SMARCA4 EP300 | 1.55e-07 | 160 | 138 | 10 | int:KLF4 |
| Interaction | KLF1 interactions | 1.80e-07 | 37 | 138 | 6 | int:KLF1 | |
| Interaction | WWTR1 interactions | SLAIN2 EP400 ARID1A CREBBP BPTF ARID1B KMT2D TLN1 LPP SMARCA4 CSTF2 PAX3 EP300 CSTF2T TBX2 | 2.12e-07 | 422 | 138 | 15 | int:WWTR1 |
| Interaction | ESRRB interactions | NCOA3 MED30 EP400 RREB1 ARID1A BPTF KMT2D OTX2 NFRKB MED25 SMARCA4 CSTF2 | 2.59e-07 | 262 | 138 | 12 | int:ESRRB |
| Interaction | ARID1B interactions | FLI1 NCOA3 ARID1A KLF4 CREBBP ARID1B NFIC SS18L1 SMARCA2 SMARCA4 | 3.97e-07 | 177 | 138 | 10 | int:ARID1B |
| Interaction | POU5F1 interactions | SALL3 EP400 WDR33 POU3F3 ARID1A KLF4 BPTF ARID1B OTX2 CSNK2A1 NFRKB SMARCA2 SMARCA4 ZFHX3 SCAF11 NONO SAP130 | 5.30e-07 | 584 | 138 | 17 | int:POU5F1 |
| Interaction | SMARCD2 interactions | FLI1 ARID1A KLF4 BPTF ARID1B NFIC SS18L1 SMARCA2 SMARCA4 TP73 | 5.40e-07 | 183 | 138 | 10 | int:SMARCD2 |
| Interaction | LHX1 interactions | 5.42e-07 | 103 | 138 | 8 | int:LHX1 | |
| Interaction | NFIB interactions | 5.89e-07 | 142 | 138 | 9 | int:NFIB | |
| Interaction | CIC interactions | EP400 EBF3 MAZ U2AF2 RREB1 POLR1G ZFHX4 NFIC CSNK2A1 PITX1 SMARCA4 ZFHX3 PAX3 EN1 NONO SAP130 TP73 TBX2 | 8.17e-07 | 673 | 138 | 18 | int:CIC |
| Interaction | NANOG interactions | SALL3 EP400 WDR33 ARID1A MYEF2 BPTF ARID1B OTX2 CSNK2A1 SMARCA2 SMARCA4 SCAF11 NONO SAP130 EP300 | 1.11e-06 | 481 | 138 | 15 | int:NANOG |
| Interaction | SOX2 interactions | SLAIN2 FLI1 BCL9L NCOA3 SALL3 COMP EP400 CUL9 BCL9 ARID1A MEF2A MYEF2 BPTF ARID1B TNRC18 KMT2D ZFHX4 NFIC PITX1 TNRC6A SMARCA2 SMARCA4 ZFHX3 SAP130 EP300 TP73 TBX2 | 1.11e-06 | 1422 | 138 | 27 | int:SOX2 |
| Interaction | ARID4B interactions | ARID1A POLR1G BPTF TNRC18 NFIC CSNK2A1 SMARCA4 DNAAF6 EN1 SAP130 | 1.16e-06 | 199 | 138 | 10 | int:ARID4B |
| Interaction | HNF1A interactions | 1.27e-06 | 80 | 138 | 7 | int:HNF1A | |
| Interaction | IRF1 interactions | 1.63e-06 | 83 | 138 | 7 | int:IRF1 | |
| Interaction | HDAC2 interactions | SLAIN2 EP400 MBD3L2 RREB1 ARID1A KLF4 CREBBP BPTF GLI1 CSNK2A1 SS18L1 LPP SMARCA2 SMARCA4 COASY CSNK2A3 NONO SAP130 EP300 TP73 | 1.83e-06 | 865 | 138 | 20 | int:HDAC2 |
| Interaction | NFIC interactions | NCOA3 RREB1 ARID1A CREBBP ARID1B KMT2D NFIC SMARCA2 SCAF11 SAP130 | 1.89e-06 | 210 | 138 | 10 | int:NFIC |
| Interaction | LHX4 interactions | 2.17e-06 | 166 | 138 | 9 | int:LHX4 | |
| Interaction | SS18 interactions | 2.42e-06 | 88 | 138 | 7 | int:SS18 | |
| Interaction | NEUROD1 interactions | 2.43e-06 | 32 | 138 | 5 | int:NEUROD1 | |
| Interaction | SMAD2 interactions | NCOA3 U2AF2 ARID1A CREBBP MEF2A BPTF ARID1B GLI1 MED25 SMARCA4 EP300 NOTCH4 TP73 | 2.52e-06 | 385 | 138 | 13 | int:SMAD2 |
| Interaction | NR1H3 interactions | 2.79e-06 | 58 | 138 | 6 | int:NR1H3 | |
| Interaction | KLF8 interactions | NCOA3 SUPT20H EP400 MAZ RREB1 CREBBP BPTF KMT2D NFIC NFRKB SAP130 EP300 | 2.84e-06 | 329 | 138 | 12 | int:KLF8 |
| Interaction | ETS2 interactions | 3.77e-06 | 61 | 138 | 6 | int:ETS2 | |
| Interaction | SOX17 interactions | 4.05e-06 | 95 | 138 | 7 | int:SOX17 | |
| Interaction | DPF3 interactions | 4.05e-06 | 95 | 138 | 7 | int:DPF3 | |
| Interaction | DPF1 interactions | 4.05e-06 | 95 | 138 | 7 | int:DPF1 | |
| Interaction | HOXB2 interactions | 4.45e-06 | 36 | 138 | 5 | int:HOXB2 | |
| Interaction | SMARCA2 interactions | FLI1 ARID1A KLF4 CREBBP ARID1B NFIC SS18L1 PITX1 SMARCA2 SMARCA4 NONO EP300 | 4.76e-06 | 346 | 138 | 12 | int:SMARCA2 |
| Interaction | CELF1 interactions | WDR33 U2AF2 PATL1 RBM20 NCOA5 RBM12 ZC3H4 NYNRIN TNRC6A RBM47 NONO | 4.84e-06 | 288 | 138 | 11 | int:CELF1 |
| Interaction | KLF15 interactions | NCOA3 EP400 MAZ BCL9 CREBBP KMT2D GLI1 NFRKB NCOA1 SAP130 EP300 | 5.17e-06 | 290 | 138 | 11 | int:KLF15 |
| Interaction | SOX15 interactions | 5.81e-06 | 141 | 138 | 8 | int:SOX15 | |
| Interaction | SMARCC2 interactions | FLI1 NCOA3 ARID1A POLR1G CREBBP ARID1B GLI1 CSNK2A1 SS18L1 SMARCA2 SMARCA4 EP300 | 5.84e-06 | 353 | 138 | 12 | int:SMARCC2 |
| Interaction | BICRA interactions | 6.55e-06 | 67 | 138 | 6 | int:BICRA | |
| Interaction | ING1 interactions | 6.95e-06 | 103 | 138 | 7 | int:ING1 | |
| Interaction | NR1H2 interactions | 7.14e-06 | 68 | 138 | 6 | int:NR1H2 | |
| Interaction | SNRNP40 interactions | BCL9L EP400 ADNP2 CUL9 U2AF2 BCL9 ARID1A RBM20 NCOA5 ARID1B ZC3H4 NFIC NFRKB SMARCA4 ZFHX3 SCAF11 | 7.73e-06 | 637 | 138 | 16 | int:SNRNP40 |
| Interaction | NCOR1 interactions | NCOA3 INSYN1 CREBBP BPTF NFIC CSNK2A1 SMARCA2 SMARCA4 NCOA1 EN1 EP300 TBX2 | 7.74e-06 | 363 | 138 | 12 | int:NCOR1 |
| Interaction | ELF5 interactions | 7.90e-06 | 147 | 138 | 8 | int:ELF5 | |
| Interaction | SMARCB1 interactions | FLI1 ARID1A CREBBP ARID1B OTX2 GLI1 SS18L1 TNRC6A SMARCA2 SMARCA4 NONO EP300 | 7.96e-06 | 364 | 138 | 12 | int:SMARCB1 |
| Interaction | ASF1A interactions | EP400 RREB1 ARID1A ARID1B KMT2D NFRKB SMARCA4 SAP130 EP300 TP73 | 8.58e-06 | 249 | 138 | 10 | int:ASF1A |
| Interaction | EP300 interactions | NCOA3 DTX1 MAZ U2AF2 PATL1 ARID1A KLF4 CREBBP MEF2A KMT2D ZC3H4 ASCL1 CSNK2A1 TLN1 SS18L1 SMARCA2 SMARCA4 NCOA1 COBL EN1 NONO EP300 GAA TP73 TBX2 | 8.81e-06 | 1401 | 138 | 25 | int:EP300 |
| Interaction | EGR1 interactions | 9.97e-06 | 72 | 138 | 6 | int:EGR1 | |
| Interaction | EN1 interactions | 1.07e-05 | 110 | 138 | 7 | int:EN1 | |
| Interaction | KAT2B interactions | FLI1 NCOA3 SUPT20H CREBBP GLI1 CSNK2A1 SMARCA2 NCOA1 EP300 TP73 | 1.09e-05 | 256 | 138 | 10 | int:KAT2B |
| Interaction | SMARCC1 interactions | FLI1 NCOA3 ARID1A CREBBP STRIP1 ARID1B SS18L1 SMARCA2 SMARCA4 NCOA1 NONO EP300 | 1.36e-05 | 384 | 138 | 12 | int:SMARCC1 |
| Interaction | EWSR1 interactions | FLI1 BCL9L NCOA3 PCLO MAZ U2AF2 POU3F3 MDFI BCL9 ARID1A CREBBP OTX2 PITX1 NFRKB SMARCA4 CSTF2 NONO EP300 CSTF2T | 1.36e-05 | 906 | 138 | 19 | int:EWSR1 |
| Interaction | CHAF1A interactions | TOB2 POU6F2 ADNP2 ARID1A POLR1G CREBBP BPTF SMARCA2 SMARCA4 NONO SAP130 | 1.39e-05 | 322 | 138 | 11 | int:CHAF1A |
| Interaction | BCL7C interactions | 1.43e-05 | 115 | 138 | 7 | int:BCL7C | |
| Interaction | H3-3A interactions | FLI1 MAZ ADNP2 U2AF2 RREB1 CREBBP BPTF KMT2D NFIC CSNK2A1 BRPF1 PITX1 NFRKB SMARCA4 SCAF11 SAP130 EP300 | 1.48e-05 | 749 | 138 | 17 | int:H3-3A |
| Cytoband | 19p13.2 | 1.13e-05 | 229 | 150 | 7 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | MBD3L5 COMP MBD3L2 COL5A3 MBD3L3 MBD3L4 MBD3L2B NFIC NCAN SMARCA4 | 3.11e-04 | 797 | 150 | 10 | chr19p13 |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.50e-07 | 25 | 92 | 5 | 775 | |
| GeneFamily | RNA binding motif containing | 1.38e-06 | 213 | 92 | 9 | 725 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.42e-06 | 17 | 92 | 4 | 486 | |
| GeneFamily | Collagens | 3.55e-06 | 46 | 92 | 5 | 490 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 7.39e-06 | 92 | 92 | 6 | 521 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.55e-05 | 15 | 92 | 3 | 529 | |
| GeneFamily | Collagens|Collagen proteoglycans | 2.54e-04 | 5 | 92 | 2 | 575 | |
| GeneFamily | Cyclins|Mediator complex | 6.23e-04 | 33 | 92 | 3 | 1061 | |
| GeneFamily | PHD finger proteins | 1.15e-03 | 90 | 92 | 4 | 88 | |
| GeneFamily | AT-rich interaction domain containing | 2.58e-03 | 15 | 92 | 2 | 418 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.51e-03 | 718 | 92 | 10 | 28 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 3.72e-03 | 18 | 92 | 2 | 624 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.72e-03 | 18 | 92 | 2 | 91 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.04e-03 | 206 | 92 | 5 | 682 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 6.04e-03 | 23 | 92 | 2 | 523 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TOB2 ZNF628 ADNP2 PHETA1 MDFI BCL9 CREBBP CDC37L1 PTK7 LPP TNRC6A MED25 SMARCA2 ZFHX3 | 4.13e-07 | 484 | 142 | 14 | MM999 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TOB2 ADNP2 PHETA1 MDFI BCL9 CREBBP CDC37L1 PTK7 LPP TNRC6A MED25 SMARCA2 ZFHX3 | 1.67e-06 | 467 | 142 | 13 | M1347 |
| Coexpression | NABA_COLLAGENS | 3.55e-06 | 43 | 142 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 3.98e-06 | 44 | 142 | 5 | M3005 | |
| Coexpression | LEIN_MIDBRAIN_MARKERS | 6.09e-06 | 83 | 142 | 6 | M1720 | |
| Coexpression | LEIN_MIDBRAIN_MARKERS | 8.55e-06 | 88 | 142 | 6 | MM717 | |
| Coexpression | BENPORATH_PRC2_TARGETS | COL4A5 FLI1 COMP KLF4 OTP OTX2 ASCL1 PITX1 CHRD ZFHX3 PAX3 EN1 TP73 TBX2 | 1.26e-05 | 650 | 142 | 14 | M8448 |
| Coexpression | NABA_CORE_MATRISOME | 1.73e-05 | 270 | 142 | 9 | MM17057 | |
| Coexpression | BENPORATH_EED_TARGETS | COL4A5 FLI1 COL12A1 COMP U2AF2 RFX6 ARID1A KLF4 OTP OTX2 ASCL1 PITX1 CHRD ZFHX3 PAX3 EN1 TP73 TBX2 | 1.76e-05 | 1059 | 142 | 18 | M7617 |
| Coexpression | NABA_CORE_MATRISOME | 2.00e-05 | 275 | 142 | 9 | M5884 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 2.45e-05 | 157 | 142 | 7 | M7733 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL4A5 FLI1 COL12A1 COMP EBF3 RFX6 KLF4 OTP OTX2 ASCL1 NFIC PITX1 CHRD ZFHX3 PAX3 EN1 TP73 TBX2 | 3.47e-05 | 1115 | 142 | 18 | M10371 |
| Coexpression | GSE12505_WT_VS_E2_2_HET_PDC_UP | 8.15e-05 | 131 | 142 | 6 | M437 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 8.87e-05 | 133 | 142 | 6 | M8880 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.04e-04 | 137 | 142 | 6 | MM990 | |
| Coexpression | GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP | 1.10e-04 | 199 | 142 | 7 | M5753 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN | 1.13e-04 | 200 | 142 | 7 | M5043 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN | 1.13e-04 | 200 | 142 | 7 | M5099 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 1.13e-04 | 200 | 142 | 7 | M5995 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | COL4A5 FLI1 COMP EBF3 KLF4 OTP OTX2 ASCL1 NFIC PITX1 CHRD ZFHX3 PAX3 EN1 TP73 TBX2 | 1.60e-04 | 1035 | 142 | 16 | M9898 |
| Coexpression | TBK1.DF_DN | 1.73e-04 | 286 | 142 | 8 | M2864 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | FLI1 COL12A1 COL15A1 EBF3 POU3F3 RBM20 EBF2 ZFHX4 ASCL1 PITX1 ZFHX3 PAX3 TBX2 | 1.66e-05 | 498 | 134 | 13 | PCBC_ratio_EB_vs_SC_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.14e-05 | 89 | 134 | 6 | gudmap_developingGonad_e11.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#1_top-relative-expression-ranked_100 | 4.18e-05 | 31 | 134 | 4 | gudmap_developingKidney_e13.5_podocyte cells_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | COL4A5 NCOA3 COL12A1 WDR33 POU3F3 CREBBP MEF2A TNRC18 NFIC CSNK2A1 LPP TNRC6A SMARCA2 RBM46 SCAF11 NONO | 4.36e-05 | 797 | 134 | 16 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | EBF3 SOBP PCLO LINGO2 KLF4 EBF2 OTX2 ZFHX4 ASCL1 PITX1 MED12L SMARCA4 NCOA1 ZFHX3 RBM47 GAA TBX2 PSD4 | 4.76e-05 | 984 | 134 | 18 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#1 | 5.16e-05 | 104 | 134 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | EBF3 SOBP PCLO LINGO2 EBF2 OTX2 ASCL1 PITX1 MED12L SMARCA4 ZFHX3 RBM47 | 7.25e-05 | 495 | 134 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | COL4A5 NCOA3 WDR33 CREBBP MEF2A TNRC18 NFIC CSNK2A1 TLN1 LPP TNRC6A SMARCA2 RBM46 SCAF11 NONO | 1.42e-04 | 790 | 134 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | TOB2 EBF3 DTX1 MDFI KLF4 EBF2 ZFHX4 NFIC GLI1 NYNRIN SMARCA2 RBM46 ZFHX3 WNK3 GAA | 1.44e-04 | 791 | 134 | 15 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | FLI1 COL12A1 COL15A1 EBF3 POU3F3 RBM20 EBF2 TNRC18 ZFHX4 ASCL1 PITX1 ZFHX3 PAX3 EN1 SPOCD1 SLC39A5 TBX2 | 1.76e-04 | 994 | 134 | 17 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | RELCH COL17A1 ADAMTS3 BCL9 KLF4 ZFHX4 PITX1 ZFHX3 PAX3 PRRX2 | 1.88e-04 | 390 | 134 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NCOA3 EBF3 POU3F3 ARID1A PANK1 CREBBP ZFHX4 ASCL1 CSNK2A1 LPP SMARCA4 ZFHX3 SCAF11 PAX3 NONO | 1.99e-04 | 815 | 134 | 15 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_500 | 2.19e-04 | 47 | 134 | 4 | gudmap_developingGonad_e11.5_testes_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.44e-04 | 259 | 134 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | FLI1 POU6F2 EBF3 WDR33 SOBP LINGO2 BCL9 CREBBP EBF2 PITX1 TBX2 | 2.93e-04 | 492 | 134 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | COL15A1 EBF3 POU3F3 LINGO2 EBF2 ZFHX4 ASCL1 NCAN PITX1 PAX3 TBX2 | 3.14e-04 | 496 | 134 | 11 | PCBC_EB_500 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-07 | 186 | 143 | 8 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-06 | 177 | 143 | 7 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-06 | 181 | 143 | 7 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-06 | 181 | 143 | 7 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-06 | 186 | 143 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-06 | 186 | 143 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-06 | 187 | 143 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.57e-06 | 188 | 143 | 7 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-06 | 121 | 143 | 6 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-06 | 121 | 143 | 6 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.76e-06 | 190 | 143 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.96e-06 | 192 | 143 | 7 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.96e-06 | 192 | 143 | 7 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.06e-06 | 193 | 143 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-06 | 196 | 143 | 7 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.75e-06 | 199 | 143 | 7 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.83e-06 | 129 | 143 | 6 | 856255fbfc7f95642000cfd7704141b2388f7c5c | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.46e-06 | 151 | 143 | 6 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-05 | 154 | 143 | 6 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.22e-05 | 158 | 143 | 6 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.27e-05 | 159 | 143 | 6 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 165 | 143 | 6 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 165 | 143 | 6 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-05 | 171 | 143 | 6 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.97e-05 | 102 | 143 | 5 | 0bbc6344d0baee47326a16a89773bb5c68a7b040 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.97e-05 | 102 | 143 | 5 | 11fbdb428824023603e9d4ee41e957ba84e7c29e | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 173 | 143 | 6 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-05 | 175 | 143 | 6 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 177 | 143 | 6 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-05 | 107 | 143 | 5 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-05 | 107 | 143 | 5 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.48e-05 | 179 | 143 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 181 | 143 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.71e-05 | 109 | 143 | 5 | a84a4a3ac19692e5595b9820d49e12ae336f4bbf | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.71e-05 | 109 | 143 | 5 | f7d7b67f7585f2ae0ac905bcf3980264cf9234b8 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.71e-05 | 109 | 143 | 5 | f007fa3dc92d6c8543585e47ccec218263b3266e | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.71e-05 | 109 | 143 | 5 | f4b9fe5335cabe48a5fae7ec51bab0d7bdb17321 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.71e-05 | 109 | 143 | 5 | 8460683529759585bd363d10a16ee13af2bd4e28 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.72e-05 | 182 | 143 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 184 | 143 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 185 | 143 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 186 | 143 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-05 | 188 | 143 | 6 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.27e-05 | 188 | 143 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.27e-05 | 188 | 143 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.27e-05 | 188 | 143 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.27e-05 | 188 | 143 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-05 | 188 | 143 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-05 | 189 | 143 | 6 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.36e-05 | 189 | 143 | 6 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 190 | 143 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 3.50e-05 | 115 | 143 | 5 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.57e-05 | 191 | 143 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.57e-05 | 191 | 143 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 192 | 143 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.67e-05 | 192 | 143 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.67e-05 | 192 | 143 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 192 | 143 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.67e-05 | 192 | 143 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.67e-05 | 192 | 143 | 6 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 193 | 143 | 6 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 195 | 143 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 4.01e-05 | 195 | 143 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 4.01e-05 | 195 | 143 | 6 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.24e-05 | 197 | 143 | 6 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-05 | 197 | 143 | 6 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.24e-05 | 197 | 143 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 199 | 143 | 6 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-05 | 199 | 143 | 6 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-05 | 199 | 143 | 6 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-05 | 199 | 143 | 6 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | distal-1-mesenchymal-Myofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.48e-05 | 199 | 143 | 6 | 58c36f5a30c6862b7f5587a0b9bc31da99e43dd5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-05 | 199 | 143 | 6 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.48e-05 | 199 | 143 | 6 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.48e-05 | 199 | 143 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.61e-05 | 200 | 143 | 6 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.61e-05 | 200 | 143 | 6 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.61e-05 | 200 | 143 | 6 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.61e-05 | 200 | 143 | 6 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.61e-05 | 200 | 143 | 6 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.61e-05 | 200 | 143 | 6 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.76e-05 | 132 | 143 | 5 | 560e836764ed7806fb18282dfebe434d30112a9a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.76e-05 | 132 | 143 | 5 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.26e-05 | 134 | 143 | 5 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma|TCGA-Testes / Sample_Type by Project: Shred V9 | 8.64e-05 | 139 | 143 | 5 | 6b58d01ce9d9ac23434333f9faf1bb0eef14ba90 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-05 | 142 | 143 | 5 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-05 | 142 | 143 | 5 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 156 | 143 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 157 | 143 | 5 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-04 | 159 | 143 | 5 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 1.62e-04 | 159 | 143 | 5 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.82e-04 | 163 | 143 | 5 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.82e-04 | 163 | 143 | 5 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.29e-06 | 172 | 141 | 9 | 1072_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.36e-06 | 173 | 141 | 9 | 5950_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.49e-06 | 175 | 141 | 9 | 1058_DN | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | SUPT20H TCF19 ZNF628 WDR33 COL5A3 ARID1A PANK1 PTK7 NCOA5 BPTF OTX2 PLEKHO2 NFIC CSNK2A1 TNRC6A SMARCA2 CSTF2 PRRX2 | 4.18e-06 | 834 | 141 | 18 | ctd:C513635 |
| Drug | hydroxylysine | 5.30e-06 | 109 | 141 | 7 | CID000001029 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.44e-05 | 176 | 141 | 8 | 1535_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.50e-05 | 177 | 141 | 8 | 6434_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.49e-05 | 190 | 141 | 8 | 1056_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A | 2.59e-05 | 191 | 141 | 8 | 1240_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 2641_DN | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.22e-09 | 5 | 137 | 4 | C3281201 | |
| Disease | Coffin-Siris syndrome | 3.08e-07 | 13 | 137 | 4 | C0265338 | |
| Disease | Bladder Neoplasm | 4.28e-06 | 140 | 137 | 7 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.49e-06 | 141 | 137 | 7 | C0005684 | |
| Disease | cancer (implicated_via_orthology) | 4.79e-06 | 268 | 137 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 5.28e-06 | 54 | 137 | 5 | C0149925 | |
| Disease | Sezary Syndrome | 7.18e-06 | 27 | 137 | 4 | C0036920 | |
| Disease | testosterone measurement | ADAMTS3 PHETA1 LINGO2 TSC22D2 RREB1 ARID1A POLR1G CDC37L1 SH2B1 EBF2 ARID1B ZFHX4 ZC3H4 ASCL1 NYNRIN SMARCA2 NCOA1 ZFHX3 SPOCD1 | 7.23e-06 | 1275 | 137 | 19 | EFO_0004908 |
| Disease | prostate cancer (is_marker_for) | 8.73e-06 | 156 | 137 | 7 | DOID:10283 (is_marker_for) | |
| Disease | breast carcinoma (is_marker_for) | 1.43e-05 | 66 | 137 | 5 | DOID:3459 (is_marker_for) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.14e-05 | 2 | 137 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.14e-05 | 2 | 137 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 2.14e-05 | 2 | 137 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.14e-05 | 2 | 137 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.14e-05 | 2 | 137 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.14e-05 | 2 | 137 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.14e-05 | 2 | 137 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.14e-05 | 2 | 137 | 2 | C0035934 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.68e-05 | 195 | 137 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | African Burkitt's lymphoma | 4.28e-05 | 15 | 137 | 3 | C0343640 | |
| Disease | Burkitt Leukemia | 4.28e-05 | 15 | 137 | 3 | C4721444 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.86e-05 | 139 | 137 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | orofacial cleft, sex interaction measurement | 5.16e-05 | 86 | 137 | 5 | EFO_0008343, MONDO_0000358 | |
| Disease | T-Cell Lymphoma | 5.25e-05 | 16 | 137 | 3 | C0079772 | |
| Disease | Neuroblastoma | 6.79e-05 | 47 | 137 | 4 | C0027819 | |
| Disease | Adenoid Cystic Carcinoma | 1.06e-04 | 100 | 137 | 5 | C0010606 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.26e-04 | 55 | 137 | 4 | C0079744 | |
| Disease | Prostatic Neoplasms | NCOA3 COL15A1 COL5A3 RFX6 ARID1A CREBBP KMT2D NFIC BRPF1 NCOA1 ZFHX3 | 1.48e-04 | 616 | 137 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA3 COL15A1 COL5A3 RFX6 ARID1A CREBBP KMT2D NFIC BRPF1 NCOA1 ZFHX3 | 1.48e-04 | 616 | 137 | 11 | C0376358 |
| Disease | waist-hip ratio | COL15A1 RBL2 DTX1 CUL9 COL5A3 LINGO2 TSC22D2 RREB1 MEF2A SH2B1 PTK7 EBF2 BPTF CSNK2A1 TNRC6A TP73 | 1.88e-04 | 1226 | 137 | 16 | EFO_0004343 |
| Disease | Delayed speech and language development | 2.12e-04 | 5 | 137 | 2 | C0454644 | |
| Disease | Alveolar rhabdomyosarcoma | 2.12e-04 | 5 | 137 | 2 | C0206655 | |
| Disease | Squamous cell carcinoma | 2.90e-04 | 124 | 137 | 5 | C0007137 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.12e-04 | 364 | 137 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | metabolic syndrome | 3.54e-04 | 200 | 137 | 6 | EFO_0000195 | |
| Disease | grapefruit juice consumption measurement | 4.43e-04 | 7 | 137 | 2 | EFO_0010094 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 5.86e-04 | 220 | 137 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | Nephroblastoma | 6.25e-04 | 36 | 137 | 3 | C0027708 | |
| Disease | Burkitt Lymphoma | 6.25e-04 | 36 | 137 | 3 | C0006413 | |
| Disease | vital capacity | FLI1 NCOA3 POU6F2 ZNF628 ADAMTS3 PCLO LINGO2 RREB1 RBM20 SH2B1 SMARCA2 NCOA1 ZFHX3 EN1 OTOG | 6.43e-04 | 1236 | 137 | 15 | EFO_0004312 |
| Disease | alcohol consumption measurement | TOB2 POU6F2 COL12A1 PCLO RFX6 LINGO2 SH2B1 OTX2 ZC3H4 PAFAH2 TNRC6A COBL ZFHX3 SCAF11 EP300 | 6.75e-04 | 1242 | 137 | 15 | EFO_0007878 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 7.22e-04 | 229 | 137 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 7.54e-04 | 9 | 137 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | uveitis | 7.54e-04 | 9 | 137 | 2 | EFO_1001231 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.17e-04 | 41 | 137 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 9.17e-04 | 41 | 137 | 3 | C0858252 | |
| Disease | Carcinoma, Transitional Cell | 9.17e-04 | 41 | 137 | 3 | C0007138 | |
| Disease | neuroblastoma (is_implicated_in) | 9.40e-04 | 10 | 137 | 2 | DOID:769 (is_implicated_in) | |
| Disease | glucagon-like peptide-1 measurement | 9.40e-04 | 10 | 137 | 2 | EFO_0008465 | |
| Disease | Breast Carcinoma | 9.50e-04 | 538 | 137 | 9 | C0678222 | |
| Disease | dyslexia | 9.78e-04 | 162 | 137 | 5 | EFO_0005424 | |
| Disease | forced expiratory volume | POU6F2 ZNF628 BCHE RFX6 BCL9 MEF2A RBM20 SH2B1 PLEKHO2 SMARCA2 EN1 | 1.17e-03 | 789 | 137 | 11 | EFO_0004314 |
| Disease | Psychotic Disorders | 1.28e-03 | 101 | 137 | 4 | C0033975 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.35e-03 | 566 | 137 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | insulin measurement | 1.59e-03 | 267 | 137 | 6 | EFO_0004467 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1.64e-03 | 50 | 137 | 3 | C1862939 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.81e-03 | 111 | 137 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | non-high density lipoprotein cholesterol measurement | AMBN ADAMTS3 ADNP2 ARID1A BPTF ZC3H4 NYNRIN NCAN SMARCA4 DERPC | 1.87e-03 | 713 | 137 | 10 | EFO_0005689 |
| Disease | nephroblastoma (is_implicated_in) | 1.88e-03 | 14 | 137 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 1.88e-03 | 14 | 137 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | Sarcoma, Spindle Cell | 1.88e-03 | 14 | 137 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 1.88e-03 | 14 | 137 | 2 | C0205944 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.88e-03 | 14 | 137 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | diffuse large B-cell lymphoma | 1.88e-03 | 14 | 137 | 2 | EFO_0000403 | |
| Disease | body fat percentage | 2.06e-03 | 488 | 137 | 8 | EFO_0007800 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.16e-03 | 15 | 137 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.16e-03 | 15 | 137 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.16e-03 | 15 | 137 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.16e-03 | 15 | 137 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.16e-03 | 15 | 137 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.16e-03 | 15 | 137 | 2 | C0079758 | |
| Disease | phosphatidylcholine measurement | 2.17e-03 | 284 | 137 | 6 | EFO_0010226 | |
| Disease | carotid atherosclerosis | 2.46e-03 | 16 | 137 | 2 | EFO_0009783 | |
| Disease | response to cranial radiation therapy, short-term memory | 2.76e-03 | 60 | 137 | 3 | EFO_0004335, EFO_0010950 | |
| Disease | cognitive function measurement | POU6F2 NRL RBL2 RFX6 LINGO2 ST3GAL3 TSC22D2 SH2B1 STRIP1 MS4A4A ARID1B KMT2D TNRC6A MED12L RBM46 | 2.77e-03 | 1434 | 137 | 15 | EFO_0008354 |
| Disease | iritis | 2.78e-03 | 17 | 137 | 2 | EFO_1000997 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.78e-03 | 17 | 137 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 3.12e-03 | 18 | 137 | 2 | OBA_2045175 | |
| Disease | tea consumption measurement | 3.13e-03 | 129 | 137 | 4 | EFO_0010091 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 3.31e-03 | 131 | 137 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 3.31e-03 | 131 | 137 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 3.31e-03 | 131 | 137 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 3.31e-03 | 131 | 137 | 4 | C3714758 | |
| Disease | obesity (implicated_via_orthology) | 3.37e-03 | 215 | 137 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.37e-03 | 215 | 137 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.47e-03 | 19 | 137 | 2 | EFO_0802076 | |
| Disease | QT interval | 3.57e-03 | 534 | 137 | 8 | EFO_0004682 | |
| Disease | Juvenile-Onset Still Disease | 3.68e-03 | 135 | 137 | 4 | C0087031 | |
| Disease | Lymphoma, Follicular | 3.85e-03 | 20 | 137 | 2 | C0024301 | |
| Disease | neoplasm of mature B-cells | 3.85e-03 | 20 | 137 | 2 | EFO_0000096 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.01e-03 | 224 | 137 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.01e-03 | 224 | 137 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | phospholipids:total lipids ratio | 4.24e-03 | 227 | 137 | 5 | EFO_0020946 | |
| Disease | Sarcoma | 4.24e-03 | 21 | 137 | 2 | C1261473 | |
| Disease | Malignant neoplasm of breast | NCOA3 SUSD3 BCHE ARID1A ARID1B KMT2D GLI1 NCOA1 SPOCD1 EP300 NOTCH4 TP73 | 4.39e-03 | 1074 | 137 | 12 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGMAYTVQGPPGQPG | 1391 | Q9UMD9 | |
| QGNLMVPVFIGCPPG | 871 | Q6ZRH7 | |
| GQPQPGMTSNGPLPD | 676 | Q09472 | |
| HGQLAQPGALNPPMG | 736 | Q09472 | |
| HGQPLNMAPQPGLGQ | 2021 | Q09472 | |
| NMAPQPGLGQVGISP | 2026 | Q09472 | |
| GGMPPTPQAAQLAGQ | 551 | Q96L91 | |
| FLALPGNPEAPGNMG | 181 | P06276 | |
| GGAQGSPMPEANPDN | 321 | Q9NP70 | |
| QGQSPLGSDLGPQML | 21 | P49747 | |
| LNPLGNNPMNIPAGG | 521 | Q92793 | |
| QGQVPGAALPNPLNM | 821 | Q92793 | |
| GAALPNPLNMLGPQA | 826 | Q92793 | |
| NLNAMQAGVPRPGVP | 2141 | Q92793 | |
| RPGVPPQQQAMGGLN | 2151 | Q92793 | |
| PMANLGVPGSPGFLN | 486 | Q9HAK2 | |
| QMHGQGPSQPCGAVP | 951 | Q8NFD5 | |
| QGGVPAPGQMPAAVT | 251 | P33240 | |
| PGPGQQLMQAAMPNG | 2316 | Q12830 | |
| PAGQMTPAGVIPGQT | 456 | Q6IQ32 | |
| NPAVPGMPNAGLPGV | 646 | Q9NTZ6 | |
| QTRGPGPSMNLPNQP | 176 | Q5T481 | |
| MVQENGQRKFGGPPP | 36 | Q8TBY0 | |
| MVQENGQRKYGGPPP | 46 | A0AV96 | |
| QPGVDQPGMVQPGRF | 496 | Q9H0J4 | |
| DQPGLVQPGAGQLGM | 731 | Q9H0J4 | |
| INQGPMAGRPPSVGP | 656 | Q8HWS3 | |
| LMNGGTPIPNGPRVE | 141 | Q2T9L4 | |
| ASETNGMGPPEGGPQ | 591 | Q6DT37 | |
| GMGPPEGGPQEAQLR | 596 | Q6DT37 | |
| GASSGQILMQPPAGN | 576 | O60393 | |
| PGSSGPATPGVNMAN | 216 | Q99811 | |
| DGGTPGRMPPQPLVN | 691 | Q08999 | |
| QPPSPAGSGSMQGPQ | 1131 | O14497 | |
| NFERQSGTPPGMGAP | 136 | Q9P260 | |
| LQGRVGQMLPPAPGF | 301 | Q86TB9 | |
| PGMGSQVQPGPGRVS | 381 | O60320 | |
| IVNSVPMNLQLGGGP | 106 | Q460N3 | |
| QQPQPPGGGLMGKFV | 216 | O43474 | |
| NNRGAMPPAPVPAGT | 396 | Q15233 | |
| MGLSNLSPGPGPSQA | 41 | Q8NDB6 | |
| MIGPNNSSIGAPSPG | 321 | Q86YW9 | |
| GGPAQTLPQMPAGPQ | 821 | Q6P4R8 | |
| GMGCQLPPPLSGQLV | 156 | A6NJ08 | |
| SQSGPGAPMKQAPAP | 956 | Q9Y6V0 | |
| GGSAQNMGPRPGAPS | 491 | Q9HCD5 | |
| NMGPRPGAPSQGLFG | 496 | Q9HCD5 | |
| MELLQGQGPVPVDGP | 96 | P54845 | |
| GMGCQLPPPLSGQLV | 156 | A0A1B0GVZ6 | |
| AVNAVIQPMGPLQPG | 91 | P63132 | |
| GAGNQNPPGMYPVTG | 336 | Q93052 | |
| SRGVGGLMNSFPPPQ | 21 | P56270 | |
| PTLQFGGQQPMCAGP | 371 | Q7L985 | |
| GQMLLSGGPRGPVPQ | 716 | Q71SY5 | |
| PENGASSLPGLMPAQ | 571 | P08151 | |
| PQRPPSTGNAGGMLS | 196 | Q02078 | |
| GAPGALNTPVPMNLF | 11 | Q86VP3 | |
| GNPAILLMGSANGGP | 246 | Q05925 | |
| AVNAVIQPMGPLQPG | 91 | P63135 | |
| AVNAVIQPMGPLQPG | 91 | Q9BXR3 | |
| HGGLMPVNGLGFPPQ | 6 | Q86Y01 | |
| ASRPQPFMGVPVQGG | 246 | O95800 | |
| PVQGGGDPIQCAMPA | 256 | O95800 | |
| MAPGPFAGPQAQQAA | 11 | Q96HR3 | |
| GMGCQLPPPLSGQLV | 156 | A6NE82 | |
| NPTIGNGLSPQVMGL | 381 | P23760 | |
| ATPNLGPVGPGMLNN | 441 | O15350 | |
| AVNAVIQPMGPLQPG | 91 | Q9QC07 | |
| LGLNPASFPRMNGPA | 471 | P0CG12 | |
| GMGASGAPQPPNILL | 21 | P34059 | |
| PMPINGGQDCPGVNF | 581 | O15072 | |
| ANPLGMPVPAATGAQ | 376 | Q8NEV1 | |
| FPAPLNGSSQMPGNP | 186 | Q96RP8 | |
| MLPPQPSAAHQGRGG | 1 | Q9C0J1 | |
| PNGLSIPGEQGRQGM | 2796 | Q99715 | |
| KMESGGAGQQPQPQP | 6 | P50553 | |
| PQTPSQLAGMLAGPA | 886 | O00512 | |
| KQPQGPGPGFSHMQG | 1261 | O00512 | |
| LPGPKGNMGLNFQGP | 211 | P29400 | |
| RNPLGEGRNQPPTMG | 826 | O75128 | |
| GNNMNSGLNKSPPLG | 231 | Q01543 | |
| VADPAMAAPQLGPGQ | 181 | Q86UU0 | |
| MAAPQLGPGQTTQLP | 186 | Q86UU0 | |
| SQAGPGPQLAQGMRL | 356 | Q8IYS4 | |
| ANPLGMPVPAAAGAQ | 376 | P68400 | |
| IPAKQGLQGAQMGQP | 111 | P10253 | |
| EAATPMPQGNGPGIP | 56 | Q99750 | |
| MPQGNGPGIPQGLDS | 61 | Q99750 | |
| PGAGPGVPQLGNMAV | 31 | Q96JQ5 | |
| NVNEGGPQFSMPLPE | 81 | Q5JT82 | |
| GPNMPGSQPQASSGP | 2446 | Q8IWT3 | |
| GPGSLTPGGAMQPQL | 276 | Q9H0L4 | |
| STIGAMGPGNIGPPQ | 56 | Q9NQM4 | |
| NGNGLQAMSGLVVPP | 581 | Q9H4W6 | |
| NGSFLMSGPPGLPGN | 1046 | P39059 | |
| APTAAPGNTGMVQGP | 1321 | Q99590 | |
| HMGGQIPNTPLPEGF | 761 | Q9BXA9 | |
| PAGVQVPAGPQTVMG | 1081 | Q9BXA9 | |
| LPSMAGGQQPPPQSL | 206 | P20264 | |
| QQTQLSMKGPPGPVG | 471 | P25940 | |
| SSPRCPQLPGGGAQM | 31 | Q7L3B6 | |
| GMGCQLPPPLSGQLV | 156 | A6NDZ8 | |
| PGPFVDMGTLQNRGP | 241 | Q9P2P1 | |
| LAAGPPPNSMGLSNS | 241 | Q5XKR4 | |
| MGVNQSVGFPPVTGP | 1 | Q99487 | |
| GMGCQLPPPLSGQLV | 156 | Q8NHZ7 | |
| TAPPAPGMGDRSGQQ | 131 | Q8TE04 | |
| PRPPCLQQNPGTMQG | 331 | Q6ZRI0 | |
| QLPGPGATLSPMGTN | 211 | P32243 | |
| LPGFQMISNNGGPAI | 81 | Q5HYA8 | |
| PGAVPGMPNSGLNNI | 231 | P78337 | |
| GDAGVPPMVQLQQSP | 721 | Q9NRF2 | |
| PPMVQLQQSPLGGDG | 726 | Q9NRF2 | |
| LPASGLATGMPQQPA | 236 | Q96L08 | |
| RGGGGMALPQPQPQS | 131 | Q8N4B1 | |
| NGGIPRMQPQASAIP | 441 | Q9P270 | |
| SQPGALIPGDPQAMS | 151 | P51531 | |
| LIPGDPQAMSQPNRG | 156 | P51531 | |
| MAAAQPSQPQGAGPG | 306 | O75157 | |
| GPAAIPNTDVNGQPM | 871 | A0AVI2 | |
| MGLGPGGQPISASQL | 336 | Q9P2K5 | |
| GNNLPPSSGLPVQMG | 1141 | Q15788 | |
| PVQMGNPRLPQGAPQ | 1151 | Q15788 | |
| VAGVMPGGPPALNQP | 106 | P78424 | |
| PEPGLQGGMEASAQP | 496 | O14594 | |
| NPVGQGIRPPMAGCN | 381 | Q9Y6Q9 | |
| PAQGPPMQGGFHLQG | 1116 | Q9Y6Q9 | |
| PGSPMPQAQSPEEGQ | 556 | Q8NDX1 | |
| GIQPQMPGGYALSQP | 366 | Q7Z5V6 | |
| GGTMAPQQPEGAKPQ | 361 | O15446 | |
| IPTQGPGGYPQDNMH | 56 | P51532 | |
| MEPAVGGPGPLIVNN | 1 | Q5VSL9 | |
| GLPFNNGLMGRGNIP | 286 | Q11203 | |
| GINNRPPTVMPGGDL | 361 | A6NHL2 | |
| PGPLNGSGQLKMPSH | 421 | P08651 | |
| GPPALQEMPINQGGE | 1986 | Q99466 | |
| SGMALQPLQAAPEPG | 336 | Q6ZMH5 | |
| PMDLPANGFSGGNQP | 966 | P55201 | |
| LQPGMSLEGPAQPQS | 41 | Q13057 | |
| PVGSGAHPQLGDPMQ | 851 | Q9H2X0 | |
| NMQTPGQGSPLPGQP | 186 | Q86WR6 | |
| PAPPTQNMNLGPGAL | 76 | O75177 | |
| GAGFRPMLPSQGAPQ | 146 | Q9Y242 | |
| AVNAVIQPMGPLQPG | 91 | P63136 | |
| NGLNPNLMVTGGPAL | 771 | O15417 | |
| AQRAQQAVPGPGPMT | 96 | A0A494C1R9 | |
| GMNGPSSLPGFPQNS | 3066 | Q86UP3 | |
| AQRAQQAVPGPGPMT | 96 | P0CV99 | |
| GNLPANNSSLGPMEP | 551 | Q2QGD7 | |
| GQPLFLHPGQFTMGP | 486 | Q13207 | |
| MGRPFIQNNPSIPAG | 266 | Q92766 | |
| NPNSPLSNPMLPGIG | 421 | A7XYQ1 | |
| GASGPENFQVGSMPP | 456 | Q9Y490 | |
| MVQGPAGCQVFQPSP | 526 | Q6ZMY3 | |
| GLQPAPMGTQQPQPE | 601 | Q9H0E3 | |
| PSGGLLPNALPSAMQ | 586 | Q8NEM7 | |
| AVNAVIQPMGPLQPG | 91 | P10266 | |
| AVNAVIQPMGPLQPG | 91 | P63133 | |
| AVNAVIQPMGPLQPG | 91 | Q9UQG0 | |
| LANGLHPVPMGPSGA | 996 | O94885 | |
| PLPQNVVGPQGGMVG | 386 | Q8IYB5 | |
| SFIPEGGMNPPINAN | 2066 | Q68DE3 | |
| GGMNPPINANASFIP | 2071 | Q68DE3 | |
| PQAPTSPNGRPMQGG | 526 | Q9UPT8 | |
| AQMRLGGLTQAPGNP | 171 | P26368 | |
| GEMQASGPPAPGTVQ | 326 | Q8TD55 | |
| GIQGPVSQGPLMGLN | 766 | Q9C0J8 | |
| MECLNGGPLQNGQPS | 746 | Q13308 | |
| SGAGGQQPPQQPRMA | 206 | Q14106 | |
| NGGLNPLFGPQQVAM | 1386 | Q8NDV7 | |
| ESVGMPPLGNPIGAN | 1686 | Q15911 | |
| PQIPGALQSGYLQPM | 3321 | Q15911 | |
| GPAGLPGAPASQMVQ | 1011 | Q5EBL2 | |
| AGPGVMTPQGLPSIQ | 1031 | Q5EBL2 | |
| VIPAQSGGPFQPGMN | 1766 | Q9BYP7 | |
| GLAGARQPGLPQPLM | 3316 | O14686 | |
| GMALPGQPGGPFLNT | 3661 | O14686 | |
| QGPQGMLGPAQVAVL | 3796 | O14686 | |
| LGDQPGSMTQNLLGP | 4141 | O14686 |